Sunteți pe pagina 1din 76

Cancer in New South Wales:

Incidence Report 2009


INFORMATION
Cancer in New South Wales:
Incidence Report 2009
State Health Publication Number
(CI) 140028
ISBN
978-1-74187-966-7
Key words
Cancer incidence, cancer statistics,
cancer mortality, trends, New South
Wales, Australia.
Suggested citation
Currow D, Thomson W. Cancer in NSW:
Incidence Report 2009. Sydney: Cancer
Institute NSW, February 2014.
Published by the Cancer Institute NSW,
February 2014
CONTACT DETAILS
Cancer Institute NSW
PO Box 41
Alexandria NSW 1435
T: +61 2 8374 5600
F: +61 2 8374 3600
E: information@cancerinstitute.org.au
W: www.cancerinstitute.org.au
COPYRIGHT
Cancer Institute NSW, February 2014
Cancer in New South Wales:
Incidence Report 2009
ACKNOWLEDGEMENTS
The Cancer Institute NSW would like to thank the following for their contribution
to this report:
Cancer Institute NSW:
Staff of the NSW Cancer Registries and Data Collection Team
Deborah Baker, Manager, Cancer Information and Analysis Unit
Wendy Thomson, Data Analyst, Cancer Information and Analysis Unit
Richard Wei, Business Objects Developer, Cancer Information and Analysis Unit
Ray Ferguson, SAS Programmer
Hui You, Biostatistician, Cancer Information and Analysis Unit
Richard Walton, Biostatistician/Manager, Cancer Information and Analysis Unit
Russell Cameron, Database Administration, IT
Narelle Grayson, Data and Information Governance, IT
Other:
Professor David Roder, University of South Australia
NSW medical records personnel, statutory notiers, clinicians and pathologists
The NSW Cancer Registries are managed and funded by the Cancer Institute NSW
under an agreement with the NSW Ministry of Health.
CANCER IN NSW: INCIDENCE REPORT 2009
Tables 2
Figures 4
Chief Cancer Officers report 6
Executive summary 7
Executive summary: Overall incidence 8
Executive summary: Trends in incidence 9
Overview of cancer incidence 10
All cancer 13
Bladder cancer 14
Bowel cancer 15
Brain cancer 16
Breast cancer 17
Cancer unknown primary (CUP) 18
Cervical cancer 19
Colon cancer 20
Head and neck cancer 21
Kidney cancer 22
Leukaemia 23
Lip cancer 24
Liver cancer 25
Lung cancer 26
Melanoma 27
Mesothelioma 28
Multiple myeloma 29
Myelodysplasia 30
Non-Hodgkin's lymphoma (NHL) 31
Oesophageal cancer 32
Ovarian cancer 33
Pancreatic cancer 34
Prostate cancer 35
Rectal cancer 36
Stomach cancer 37
Testicular cancer 38
Thyroid cancer 39
Uterine cancer 40
Childhood cancer 41
Cancer in Aboriginal peoples 43
Appendices 45
CONTENTS
CANCER INSTITUTE NSW 1
CANCER IN NSW: INCIDENCE REPORT 2009
TABLES
Table 1a New cancer cases, NSW, 2009 7
Table 1b Most common cancers, NSW, 2009 7
Table 2 Differences by age: New cases by age group, NSW, 2009 8
Table 3 Trends in cancer cases, NSW, 20002009 9
Table 4a New cancer cases, all people, NSW, 2009 10
Table 4b New cancer cases, clinical groupings, all people, NSW, 2009 10
Table 5a New cancer cases, males, NSW, 2009 11
Table 5b New cancer cases, clinical groupings, Males, NSW, 2009 11
Table 6a New cancer cases, females, NSW, 2009 12
Table 6b New cancer cases, clinical groupings, Females, NSW, 2009 12
Table 7 All cancer statistics, NSW, 2000, 2009 13
Table 8 Bladder cancer statistics, NSW, 2000, 2009 14
Table 9 Bowel cancer statistics, NSW, 2000, 2009 15
Table 10 Brain cancer statistics, NSW, 2000, 2009 16
Table 11 Breast cancer statistics, NSW, 2000, 2009 17
Table 12 Cancer unknown primary (CUP) statistics, NSW, 2000, 2009 18
Table 13 Cervical cancer statistics, NSW, 2000, 2009 19
Table 14 Colon cancer statistics, NSW, 2000, 2009 20
Table 15 Head and neck cancer statistics, NSW, 2000, 2009 21
Table 16 Kidney cancer statistics, NSW, 2000, 2009 22
Table 17 Leukaemia statistics, NSW, 2000, 2009 23
Table 18 Lip cancer statistics, NSW, 2000, 2009 24
Table 19 Liver cancer statistics, NSW, 2000, 2009 25
Table 20 Lung cancer statistics, NSW, 2000, 2009 26
Table 21 Melanoma statistics, NSW, 2000, 2009 27
Table 22 Mesothelioma statistics, NSW, 2000, 2009 28
Table 23 Multiple myeloma statistics, NSW, 2000, 2009 29
Table 24 Myelodysplasia statistics, NSW, 2000, 2009 30
Table 25 Non-Hodgkin's lymphoma (NHL) statistics, NSW, 2000, 2009 31
Table 26 Oesophageal cancer statistics, NSW, 2000, 2009 32
Table 27 Ovarian cancer statistics, NSW, 2000, 2009 33
Table 28 Pancreatic cancer statistics, NSW, 2000, 2009 34
Table 29 Prostate cancer statistics, NSW, 2000, 2009 35
Table 30 Rectal cancer statistics, NSW, 2000, 2009 36
Table 31 Stomach cancer statistics, NSW, 2000, 2009 37
Table 32 Testicular cancer statistics, NSW, 2000, 2009 38
Table 33 Thyroid cancer statistics, NSW, 2000, 2009 39
CANCER INSTITUTE NSW 2
CANCER IN NSW: INCIDENCE REPORT 2009
TABLES (CONT.)
Table 34 Uterine cancer statistics, NSW, 2000, 2009 40
Table 35 Childhood cancer by age group, NSW, 20052009 42
Table 36a New cancer cases, Aboriginal peoples, NSW, 19992007 43
Table 36b Most common cancers, Aboriginal peoples, NSW, 19992007 43
Table 37 Differences by age: New cases by age group, Aboriginal peoples, NSW, 19992007 44
Table A2.1 Cancer groups used in this report 46
Table A2.2 Clinical grouping categories 47
Table A3.1 Proportion of NSW death certificate only cancer cases for 20042008 by tumour group 49
Table A3.2 Proportion of NSW death certificate only cancer cases for 20042008 by 5 year age group 50
Table A5.1 Estimated residential population of NSW, 30 June 2009 52
Table A6.1 Cumulative risk of incidence by cancer type, age and sex, NSW, 2009 53
Table A7.1 New cases of cancers, number and percentage of all cancers by type, age and sex, NSW, 2009 56
Table A8.1 Age-specific and age-standardised incidence rates per 100,000 population by cancer type and sex, NSW,
2009
63
Table A9.1 Summary of age-standardised cancer incidence, crude and cumulative incidence rates, NSW, 2009 71
CANCER INSTITUTE NSW 3
CANCER IN NSW: INCIDENCE REPORT 2009
FIGURES
Figure 1 New cancer cases, all people, NSW, 2009 7
Figure 2a All cancer, ASR, NSW, 19732009 13
Figure 2b All cancer, new cases by age group, NSW, 2009 13
Figure 3a Bladder cancer, ASR, NSW, 19732009 14
Figure 3b Bladder cancer, new cases by age group, NSW, 2009 14
Figure 4a Bowel cancer, ASR, NSW, 19732009 15
Figure 4b Bowel cancer, new cases by age group, NSW, 2009 15
Figure 5a Brain cancer, ASR, NSW, 19732009 16
Figure 5b Brain cancer, new cases by age group, NSW, 2009 16
Figure 6a Breast cancer, ASR, NSW, 19732009 17
Figure 7b Breast cancer, new cases by age group, NSW, 2009 17
Figure 7a Cancer unknown primary (CUP), ASR, NSW, 19732009 18
Figure 7b Cancer unknown primary (CUP), new cases by age group, NSW, 2009 18
Figure 8a Cervical cancer, ASR, NSW, 19732009 19
Figure 8b Cervical cancer, new cases by age group, NSW, 2009 19
Figure 9a Colon cancer, ASR, NSW, 19732009 20
Figure 9b Colon cancer, new cases by age group, NSW, 2009 20
Figure 10a Head and neck cancer, ASR, NSW, 19732009 21
Figure 10b Head and neck cancer, new cases by age group, NSW, 2009 21
Figure 11a Kidney cancer, ASR, NSW, 19732009 22
Figure 11b Kidney cancer, new cases by age group, NSW, 2009 22
Figure 12a Leukaemia, ASR, NSW, 19732009 23
Figure 12b Leukaemia, new cases by age group, NSW, 2009 23
Figure 13a Lip cancer, ASR, NSW, 19732009 24
Figure 13b Lip cancer, new cases by age group, NSW, 2009 24
Figure 14a Liver cancer, ASR, NSW, 19732009 25
Figure 14b Liver cancer, new cases by age group, NSW, 2009 25
Figure 15a Lung cancer, ASR, NSW, 19732009 26
Figure 15b Lung cancer, new cases by age group, NSW, 2009 26
Figure 16a Melanoma, ASR, NSW, 19732009 27
Figure 16b Melanoma, new cases by age group, NSW, 2009 27
Figure 17a Mesothelioma, ASR, NSW, 19732009 28
Figure 17b Mesothelioma, new cases by age group, NSW, 2009 28
Figure 18a Multiple myeloma, ASR, NSW, 19732009 29
Figure 18b Multiple myeloma, new cases by age group, NSW, 2009 29
Figure 19a Myelodyspasia, ASR, NSW, 19732009 30
Figure 19b Myelodyspasia, new cases by age group, NSW, 2009 30
CANCER INSTITUTE NSW 4
CANCER IN NSW: INCIDENCE REPORT 2009
FIGURES (CONT.)
Figure 20a Non-Hodgkin's lymphoma (NHL), ASR, NSW, 19732009 31
Figure 20b Non-Hodgkin's lymphoma (NHL), new cases by age group, NSW, 2009 31
Figure 21a Oesophageal cancer, ASR, NSW, 19732009 32
Figure 21b Oesophageal cancer, new cases by age group, NSW, 2009 32
Figure 22a Ovarian cancer, ASR, NSW, 19732009 33
Figure 22b Ovarian cancer, new cases by age group, NSW, 2009 33
Figure 23a Pancreatic cancer, ASR, NSW, 19732009 34
Figure 23b Pancreatic cancer, new cases by age group, NSW, 2009 34
Figure 24a Prostate cancer, ASR, NSW, 19732009 35
Figure 24b Prostate cancer, new cases by age group, NSW, 2009 35
Figure 25a Rectal cancer, ASR, NSW, 19732009 36
Figure 25b Rectal cancer, new cases by age group, NSW, 2009 36
Figure 26a Stomach cancer, ASR, NSW, 19732009 37
Figure 26b Stomach cancer, new cases by age group, NSW, 2009 37
Figure 27a Testicular cancer, ASR, NSW, 19732009 38
Figure 27b Testicular cancer, new cases by age group, NSW, 2009 38
Figure 28a Thyroid cancer, ASR, NSW, 19732009 39
Figure 28b Thyroid cancer, new cases by age group, NSW, 2009 39
Figure 29a Uterine cancer, ASR, NSW, 19732009 40
Figure 29b Uterine cancer, new cases by age group, NSW, 2009 40
Figure 30a Childhood cancer incidence (<15 years), NSW, 20052009 41
Figure 30b Trends in childhood cancer, NSW, 19752009 41
Figure 31 New cancer cases, Aboriginal peoples , NSW, 19992007 43
Figure A5.1 Estimated residential population of NSW, 30 June 2009 52
CANCER INSTITUTE NSW 5
CANCER IN NSW: INCIDENCE REPORT 2009
CHIEF CANCER OFFICERS REPORT
Cancer is a major public health issue in Australia and many
parts of the world. The lifetime risk of being diagnosed with
cancer by age 85 is still one in two males and one in three
females. The absolute number of cases of cancer is
increasing as our population ages and grows, and because of
the lifestyle behaviours we adopt.
Collecting and reporting important data about cancer means
we continue to gain a clearer understanding of the impact of
cancer in NSW, and provide important information about
what is needed to improve cancer outcomes.
The Cancer in New South Wales: Incidence Report 2009
provides the latest information available on cancer incidence
and trends in NSW.
Overall, cancer incidence in 2009 increased by 2.5 per cent
on 2008, totalling 37,525 new cancer cases*. From 1999 to
2009, cancer incidence in men continued to increase
significantly while there was no significant change in women.
Prostate cancer in men and breast cancer in women remain
the most common cancers.
Promisingly, cancers that continue to show decreasing
incidence rates include lung cancer in males; oesophageal
cancer in females; and bladder cancer, leukaemia and
stomach cancer in both males and females.
Cancers still showing significant increases in incidence rates
include liver, pancreatic and thyroid cancer in both males
and females; lung and uterine cancer in females; and prostate
cancer in males. Lip, head and neck, melanoma and cervical
cancer rates are plateauing and showing no significant change
in trends for the latest 10-year period of data.
New to this report is cancer incidence in NSW Aboriginal
peoples (19992007)**. While prostate and breast cancer
remain the most common in Aboriginal males and females
respectively, there are some notable differences in the
incidence of other cancers. Lung cancer incidence ranked
second in both Aboriginal males and females. Head and neck
cancer in Aboriginal males and cervical cancer in Aboriginal
females ranks in the top five cancers in NSW Aboriginal
Peoples in (19992007); however, these appear much
further down the rankings in NSW males and females in
2009.
Overall, these data enable us to gain crucial insights into the
specific impact of cancer on Aboriginal peoples, and to
identify how we can best focus our efforts on improving
health outcomes in Aboriginal communities.
Cancer control programs depend on quality data. I would
like to acknowledge the significant contribution of the staff at
the Cancer Institute NSW whom provide unparalleled
information on how to best minimise the impacts of cancer
across our community.
Professor David Currow
Chief Cancer Officer and CEO, Cancer Institute NSW
* Previously, we published the annual Cancer Incidence and Mortality Report; however, mortality data is not available for 2009 due to the delayed release of the Australian Bureau of
Statistics (ABS) 2009 data on coded cause of deaths. As a result: there has been a delay in the release of this report; all survival data has been removed from the report; and the 2009
incidence data is expected to be underreported by an estimated 1.7 per cent of all cancers, due to the missing cases that are usually identified during death certificate processing by the
ABS. Appendix 3 contains more details.
** The data reported reflects the data that was publicised in the Cancer in Aboriginal peoples in NSW: Incidence, mortality and survival 2012 (see page 43 for more information).
CANCER INSTITUTE NSW 6
CANCER IN NSW: INCIDENCE REPORT 2009
Table 1b Most common cancers, NSW, 2009
All
People
Cancer Number % of Total
Prostate 7,277 19.4%
Bowel 4,744 12.6%
Breast 4,648 12.4%
Melanoma 3,705 9.9%
Lung 3,339 8.9%
Female
Cancer Number % of Total
Breast 4,606 28.8%
Bowel 2,144 13.4%
Melanoma 1,527 9.5%
Colon 1,443 9%
Lung 1,348 8.4%
Male
Rank Cancer Number % of Total
1 Prostate 7,277 33.8%
2 Bowel 2,600 12.1%
3 Melanoma 2,178 10.1%
4 Lung 1,991 9.2%
5 Colon 1,526 7.1%
Key Facts

37,525 people (21,531 males and 15,994 females)


were diagnosed with invasive cancer in NSW.

Males were 1.3 times more likely to be diagnosed


with cancer than females.

Cancers of the prostate, bowel, breast, melanoma


and lung were the most common, and were
responsible for 63 per cent of all new cases.

There were 230 additional cases of breast cancer in


2009 compared with 2008.

Breast cancer as a proportion of female cancer


increased by 0.7 per cent compared to 2008.

There were 372 additional cases of prostate cancer


in 2009 compared with 2008.

Prostate cancer as a proportion of male cancer


increased by 0.7 per cent compared to 2008.
Table 1a New cancer cases, NSW, 2009
Sex Cases ASR*
Males 21,531 588.2
Females 15,994 393.5
All People 37,525 481.9
EXECUTIVE SUMMARY
Figure 1 New cancer cases, all people, NSW, 2009
Includes invasive cancers only and excludes non-melanoma skin cancers (NMSC).
* Age-standardised rate, standardised to the Australian 2001 population.
Excludes death certificate only (DCO) cases in 2009. DCO cases are incident cases identified during death certificate processing. For further information refer to Appendix 3.
Cancers of the colon and rectum are presented in this report both separately and together as bowel.
Melanoma refers to melanoma of the skin only.
CANCER INSTITUTE NSW 7
Male
CANCER IN NSW: INCIDENCE REPORT 2009
Table 2 Differences by age: New cases by age group, NSW, 2009
Key Facts

The risk or likelihood of being diagnosed with cancer increases with age.

82 per cent of lung cancers, 78 per cent of bowel cancers, 80 per cent of prostate cancers, 61 per cent of melanoma and 53 per
cent of breast cancers were diagnosed in people aged 60 years and over.

49 per cent of all melanomas were found in males and females aged 3064 years.

52 per cent of breast cancer cases (2,397) were aged between the BreastScreen NSW target age range of 5069 years at
diagnosis.

82 per cent of cervical cancer cases (206) were aged between the Cervical Screening Program target age range of 2069 years at
diagnosis.
EXECUTIVE SUMMARY: OVERALL INCIDENCE
Cancer Number % of Total
Leukaemia 41 21.1%
Brain 12 6.2%
Other endocrine 11 5.7%
NHL 9 4.6%
Liver 4 2.1%
Testicular 41 13.1%
Hodgkin's 28 9%
Melanoma 17 5.4%
NHL 17 5.4%
Leukaemia 16 5.1%
Melanoma 343 7.7%
Prostate 201 4.5%
Bowel 186 4.2%
Testicular 169 3.8%
NHL 110 2.5%
Prostate 1,241 19.4%
Melanoma 413 6.4%
Bowel 384 6%
Lung 252 3.9%
Rectal 200 3.1%
Prostate 2,839 27.9%
Bowel 699 6.9%
Lung 564 5.5%
Melanoma 536 5.3%
Colon 382 3.7%
Prostate 2,131 22.8%
Bowel 814 8.7%
Lung 657 7%
Melanoma 521 5.6%
Colon 516 5.5%
Prostate 865 13.1%
Bowel 513 7.8%
Lung 431 6.5%
Colon 352 5.3%
Melanoma 347 5.3%
Age Group
Cases
(% of Total)
014 194 (0.5%)
1524 312 (0.8%)
2549 4,480 (11.9%)
5059 6,406 (17.1%)
6069 10,192 (27.2%)
7079 9,338 (24.9%)
80+ 6,603 (17.6%)
Cancer Number % of Total
Leukaemia 32 16.5%
Brain 17 8.8%
Hodgkin's 7 3.6%
Kidney 6 3.1%
Bone 4 2.1%
Melanoma 28 9%
Thyroid 22 7.1%
Hodgkin's 16 5.1%
NHL 11 3.5%
Leukaemia 10 3.2%
Breast 1,035 23.1%
Melanoma 366 8.2%
Thyroid 257 5.7%
Bowel 174 3.9%
Cervical 125 2.8%
Breast 1,120 17.5%
Melanoma 289 4.5%
Bowel 283 4.4%
Lung 207 3.2%
Uterine 184 2.9%
Breast 1,252 12.3%
Bowel 489 4.8%
Lung 399 3.9%
Colon 316 3.1%
Melanoma 316 3.1%
Breast 696 7.5%
Bowel 615 6.6%
Colon 450 4.8%
Lung 386 4.1%
Melanoma 271 2.9%
Bowel 575 8.7%
Breast 498 7.5%
Colon 444 6.7%
Lung 290 4.4%
Melanoma 257 3.9%
Female
Excludes death certificate only (DCO) cases in 2009. DCO cases are incident cases identified during death certificate processing. For further information refer to Appendix 3.
Cancers of the colon and rectum are presented in this report both separately and together as bowel.
Melanoma refers to melanoma of the skin only.
CANCER INSTITUTE NSW 8
CANCER IN NSW: INCIDENCE REPORT 2009
Table 3 Trends in cancer cases, NSW, 20002009
TRENDS IN INCIDENCE
CASES ASR* per 100,000
CANCER SITE 2000 2009 2000 2009 2000 2009 2000 2009
All cancer 16,014 21,531 13,287 15,994 536.9 588.2 381.1 393.5
Bladder cancer 596 539 203 208 21 15.2 5.5 4.6
Bowel cancer 2,366 2,600 1,818 2,144 79.3 71.7 50.8 50.9
Brain cancer 264 300 176 205 8.4 8.2 5.2 5.3
Breast cancer 33 42 3,798 4,606 1.1 1.1 112.7 116.3
Cancer unknown primary (CUP) 619 472 603 436 21.4 13.3 16.1 9.7
Cervical cancer 286 250 8.5 6.8
Colon cancer 1,382 1,526 1,250 1,443 47 42.4 34.7 33.7
Head and neck cancer 645 744 238 267 21 20.1 6.7 6.7
Kidney cancer 500 648 351 389 16.4 17.7 9.8 9.5
Leukaemia 548 540 356 356 18.4 15.1 10 8.7
Lip cancer 185 200 71 72 6.1 5.6 1.9 1.7
Liver cancer 194 367 70 140 6.3 10.1 2 3.3
Lung cancer 1,861 1,991 966 1,348 62.9 54.9 27.3 32.2
Melanoma 1,641 2,178 1,186 1,527 53.7 60.1 34.8 38.3
Mesothelioma 135 184 26 42 4.5 5.1 0.7 0.9
Multiple myeloma 198 266 199 170 6.8 7.3 5.5 4
Myelodysplasia - 187 - 138 - 5.5 - 3.1
Non-Hodgkin's lymphoma (NHL) 657 760 584 618 21.9 21 16.4 14.9
Oesophageal cancer 216 278 121 126 7.2 7.6 3.2 2.8
Ovarian cancer 389 395 11.2 9.8
Pancreatic cancer 285 444 323 388 9.8 12.3 8.7 9
Prostate cancer 3,892 7,277 131.5 194.1
Rectal cancer 984 1,074 568 701 32.4 29.4 16.1 17.1
Stomach cancer 416 430 225 222 14.5 11.8 6.2 5.2
Testicular cancer 204 227 6.3 6.6
Thyroid cancer 98 195 303 583 3.1 5.4 9.2 15.9
Uterine cancer 498 685 14.4 16.8
Increasing trend (p<0.05) over years 2000 to 2009.
Decreasing trend (p<0.05) over years 2000 to 2009.
* Age-standardised rate, standardised to the Australian 2001 population.
Excludes death certificate only (DCO) cases in 2009. DCO cases are incident cases identified during death certificate processing. For further information refer to Appendix 3.
Cancers of the colon and rectum are presented in this report both separately and together as bowel.
Melanoma refers to melanoma of the skin only.
Male Male Female Female
CANCER INSTITUTE NSW 9
CANCER IN NSW: INCIDENCE REPORT 2009
OVERVIEW OF CANCER INCIDENCE
People
ASR per 100,000
Cancer Site Cases Per cent Crude Rate World Aust 2001 Risk to age 85
All sites 37,525 100% 530.8 325.2 481.9 1 in 2
Prostate 7,277 19.4% 102.9 62.8 91.9 1 in 8
Bowel 4,744 12.6% 67.1 37.6 60.5 1 in 12
Breast 4,648 12.4% 65.7 44.1 60.5 1 in 15
Melanoma 3,705 9.9% 52.4 33.2 48.2 1 in 18
Lung 3,339 8.9% 47.2 26.4 42.3 1 in 17
Colon 2,969 7.9% 42.0 22.5 37.7 1 in 19
Rectal 1,775 4.7% 25.1 15.1 22.8 1 in 34
NHL 1,378 3.7% 19.5 11.9 17.8 1 in 44
Kidney 1,037 2.8% 14.7 9.1 13.3 1 in 58
Head and neck 1,011 2.7% 14.3 9.2 13.1 1 in 63
CUP 908 2.4% 12.8 6.4 11.3 1 in 67
Leukaemia 896 2.4% 12.7 8.6 11.6 1 in 69
Pancreatic 832 2.2% 11.8 6.2 10.5 1 in 66
Thyroid 778 2.1% 11.0 8.6 10.7 1 in 101
Bladder 747 2% 10.6 5.1 9.3 1 in 74
Uterine 685 1.8% 9.7 6.2 8.8 1 in 96
Stomach 652 1.7% 9.2 5.2 8.3 1 in 89
Liver 507 1.4% 7.2 4.4 6.6 1 in 114
Brain 505 1.3% 7.1 5.2 6.7 1 in 129
Myeloma 436 1.2% 6.2 3.5 5.5 1 in 131
Oesophagus 404 1.1% 5.7 3.2 5.1 1 in 149
Ovarian 395 1.1% 5.6 3.6 5.1 1 in 167
Myelodysplasia 325 0.9% 4.6 2.0 4.0 1 in 181
Lip 272 0.7% 3.8 2.5 3.6 1 in 244
Cervical 250 0.7% 3.5 2.7 3.5 1 in 320
ASR per 100,000
Clinical Group Cases Per cent Crude Rate World Aust 2001 Risk to age 85
All cancers 37,525 100% 530.8 325.2 481.9 1 in 2
Urogenital 9,321 24.8% 131.8 80.2 118.3 1 in 7
Colorectal 4,744 12.6% 67.1 37.6 60.5 1 in 12
Breast 4,648 12.4% 65.7 44.1 60.5 1 in 15
Skin 3,996 10.6% 56.5 35.9 52.0 1 in 16
Respiratory 3,600 9.6% 50.9 28.3 45.6 1 in 16
Lymphohaematopoietic 2,894 7.7% 40.9 26.5 37.5 1 in 22
Upper gastrointestinal 2,762 7.4% 39.1 21.8 35.1 1 in 21
Gynaecological 1,470 3.9% 20.8 13.6 19.2 1 in 46
Head and neck 1,011 2.7% 14.3 9.2 13.1 1 in 63
CUP 908 2.4% 12.8 6.4 11.3 1 in 67
Thyroid and other endocrine 819 2.2% 11.6 9.3 11.3 1 in 96
Neurological 544 1.4% 7.7 5.6 7.2 1 in 120
Myelodysplasia 452 1.2% 6.4 3.1 5.7 1 in 132
Bone and other connective tissue 265 0.7% 3.7 2.8 3.6 1 in 250
Eye 91 0.2% 1.3 0.9 1.2 1 in 672
Table 4b New cancer cases, clinical groupings, all people, NSW, 2009
Age-standardised rate
Standardised to the world population 1960 SEGI.
Standardised to the Australian 2001 population
Excludes death certificate only (DCO) cases in 2009. DCO cases are incident cases identified during death certificate processing. For further information refer to Appendix 3.
Cancers of the colon and rectum are presented in this report both separately and together as bowel.
Melanoma refers to melanoma of the skin only.
Table 4a New cancer cases, all people, NSW, 2009
CANCER INSTITUTE NSW 10
CANCER IN NSW: INCIDENCE REPORT 2009
OVERVIEW OF CANCER INCIDENCE
Males
ASR per 100,000
Cancer Site Cases Per cent Crude Rate World Aust 2001 Risk to age 85
All sites 21,531 100% 613.8 383.6 588.2 1 in 2
Prostate 7,277 33.8% 207.4 129.8 194.1 1 in 4
Bowel 2,600 12.1% 74.1 44.0 71.7 1 in 10
Melanoma 2,178 10.1% 62.1 39.8 60.1 1 in 14
Lung 1,991 9.2% 56.8 32.9 54.9 1 in 13
Colon 1,526 7.1% 43.5 25.0 42.4 1 in 17
Rectal 1,074 5% 30.6 19.0 29.4 1 in 26
NHL 760 3.5% 21.7 14.2 21.0 1 in 38
Head and neck 744 3.5% 21.2 13.9 20.1 1 in 40
Kidney 648 3% 18.5 11.8 17.7 1 in 45
Leukaemia 540 2.5% 15.4 10.7 15.1 1 in 54
Bladder 539 2.5% 15.4 8.2 15.2 1 in 47
CUP 472 2.2% 13.5 7.4 13.3 1 in 56
Pancreatic 444 2.1% 12.7 7.2 12.3 1 in 57
Stomach 430 2% 12.3 7.3 11.8 1 in 61
Liver 367 1.7% 10.5 6.7 10.1 1 in 74
Brain 300 1.4% 8.6 6.2 8.2 1 in 103
Oesophagus 278 1.3% 7.9 4.8 7.6 1 in 99
Myeloma 266 1.2% 7.6 4.5 7.3 1 in 103
Testicular 227 1.1% 6.5 6.0 6.6 1 in 216
Lip 200 0.9% 5.7 3.9 5.6 1 in 153
Thyroid 195 0.9% 5.6 4.3 5.4 1 in 187
Myelodysplasia 187 0.9% 5.3 2.6 5.5 1 in 147
Mesothelioma 184 0.9% 5.2 2.8 5.1 1 in 123
Connective tissue, peripheral nerves 111 0.5% 3.2 2.4 3.1 1 in 289
Hodgkin's 106 0.5% 3.0 2.8 3.0 1 in 368
ASR per 100,000
Clinical Group Cases Per cent Crude Rate World Aust 2001 Risk to age 85
All cancers 21,531 100% 613.8 383.6 588.2 1 in 2
Urogenital 8,724 40.5% 248.7 156.5 234.5 1 in 4
Colorectal 2,600 12.1% 74.1 44.0 71.7 1 in 10
Skin 2,395 11.1% 68.3 43.9 66.1 1 in 13
Respiratory 2,194 10.2% 62.5 36.1 60.5 1 in 12
Upper gastrointestinal 1,698 7.9% 48.4 29.1 46.7 1 in 16
Lymphohaematopoietic 1,672 7.8% 47.7 32.2 46.4 1 in 18
Head and neck 744 3.5% 21.2 13.9 20.1 1 in 40
CUP 472 2.2% 13.5 7.4 13.3 1 in 56
Neurological 318 1.5% 9.1 6.6 8.7 1 in 97
Myelodysplasia 252 1.2% 7.2 3.7 7.3 1 in 111
Thyroid and other endocrine 219 1% 6.2 5.1 6.1 1 in 169
Bone and other connective tissue 152 0.7% 4.3 3.4 4.3 1 in 212
Eye 49 0.2% 1.4 0.9 1.3 1 in 548
Breast 42 0.2% 1.2 0.7 1.1 1 in 744
Gynaecological - - -
Table 5b New cancer cases, clinical groupings, males, NSW, 2009
Age-standardised rate
Standardised to the world population 1960 SEGI.
Standardised to the Australian 2001 population
Excludes death certificate only (DCO) cases in 2009. DCO cases are incident cases identified during death certificate processing. For further information refer to Appendix 3.
Cancers of the colon and rectum are presented in this report both separately and together as bowel.
Melanoma refers to melanoma of the skin only.
Table 5a New cancer cases, males, NSW, 2009
CANCER INSTITUTE NSW 11
CANCER IN NSW: INCIDENCE REPORT 2009
OVERVIEW OF CANCER INCIDENCE
Females
ASR per 100,000
Cancer Site Cases Per cent Crude Rate World Aust 2001 Risk to age 85
All sites 15,994 100% 449.0 273.6 393.5 1 in 3
Breast 4,606 28.8% 129.3 85.7 116.3 1 in 8
Bowel 2,144 13.4% 60.2 31.7 50.9 1 in 15
Melanoma 1,527 9.5% 42.9 27.4 38.3 1 in 24
Colon 1,443 9% 40.5 20.2 33.7 1 in 21
Lung 1,348 8.4% 37.8 20.7 32.2 1 in 22
Rectal 701 4.4% 19.7 11.5 17.1 1 in 46
Uterine 685 4.3% 19.2 12.0 16.8 1 in 50
NHL 618 3.9% 17.4 9.8 14.9 1 in 52
Thyroid 583 3.6% 16.4 12.9 15.9 1 in 70
CUP 436 2.7% 12.2 5.5 9.7 1 in 79
Ovarian 395 2.5% 11.1 7.0 9.8 1 in 87
Kidney 389 2.4% 10.9 6.5 9.5 1 in 79
Pancreatic 388 2.4% 10.9 5.3 9.0 1 in 76
Leukaemia 356 2.2% 10.0 6.8 8.7 1 in 93
Head and neck 267 1.7% 7.5 4.7 6.7 1 in 128
Cervical 250 1.6% 7.0 5.3 6.8 1 in 164
Stomach 222 1.4% 6.2 3.2 5.2 1 in 146
Bladder 208 1.3% 5.8 2.4 4.6 1 in 150
Brain 205 1.3% 5.8 4.3 5.3 1 in 165
Myeloma 170 1.1% 4.8 2.5 4.0 1 in 174
Liver 140 0.9% 3.9 2.1 3.3 1 in 221
Myelodysplasia 138 0.9% 3.9 1.7 3.1 1 in 223
Other female genital organs 136 0.9% 3.8 2.2 3.3 1 in 233
Oesophagus 126 0.8% 3.5 1.6 2.8 1 in 271
Gallbladder 125 0.8% 3.5 1.7 2.9 1 in 233
ASR per 100,000
Clinical Group Cases Per cent Crude Rate World Aust 2001 Risk to age 85
All cancers 15,994 100% 449.0 273.6 393.5 1 in 3
Breast 4,606 28.8% 129.3 85.7 116.3 1 in 8
Colorectal 2,144 13.4% 60.2 31.7 50.9 1 in 15
Skin 1,601 10% 44.9 28.6 40.1 1 in 23
Gynaecological 1,470 9.2% 41.3 26.6 36.9 1 in 24
Respiratory 1,406 8.8% 39.5 21.6 33.5 1 in 22
Lymphohaematopoietic 1,222 7.6% 34.3 21.2 29.9 1 in 27
Upper gastrointestinal 1,064 6.7% 29.9 14.9 24.8 1 in 30
Thyroid and other endocrine 600 3.8% 16.8 13.4 16.3 1 in 68
Urogenital 597 3.7% 16.8 8.9 14.1 1 in 52
CUP 436 2.7% 12.2 5.5 9.7 1 in 79
Head and neck 267 1.7% 7.5 4.7 6.7 1 in 128
Neurological 226 1.4% 6.3 4.8 5.9 1 in 151
Myelodysplasia 200 1.3% 5.6 2.7 4.6 1 in 156
Bone and other connective tissue 113 0.7% 3.2 2.3 2.9 1 in 298
Eye 42 0.3% 1.2 0.9 1.1 1 in 822
Table 6b New cancer cases, clinical groupings, females, NSW, 2009
Age-standardised rate
Standardised to the world population 1960 SEGI.
Standardised to the Australian 2001 population
Excludes death certificate only (DCO) cases in 2009. DCO cases are incident cases identified during death certificate processing. For further information refer to Appendix 3.
Cancers of the colon and rectum are presented in this report both separately and together as bowel.
Melanoma refers to melanoma of the skin only.
Table 6a New cancer cases, females, NSW, 2009
CANCER INSTITUTE NSW 12
Excludes death certificate only (DCO) cases in 2009. DCO cases are incident cases identified during death certificate processing. For further information refer to Appendix 3.
* Age-standardised rate, standardised to the Australian 2001 population.
** APC is the average annual percent change in ASR* calculated from a log linear model, fitted to rates over the years 2000 to 2009. For further information refer to Appendix 4.
Figure 2b All cancer, new cases by age group, NSW, 2009
Incidence Male Female
All
People
New cases 2009: 21,531 15,994 37,525
New cases 2000: 16,014 13,287 29,301
ASR* per 100,000 2009: 588.2 393.5 481.9
ASR* per 100,000 2000: 536.9 381.1 446.3
APC** between 2000 and 2009: 1.3% 0.2% 0.9%
Crude rate per 100,000 2009: 613.8 449 530.8
Risk of diagnosis by age 85 years
2009:
1 in 2 1 in 3 1 in 2
Median age at diagnosis 2009: 68 65 67
Key Facts

The likelihood or risk of developing cancer is one in two in


males and one in three in females by the age of 85 years.

The rate of cancer incidence in males has increased significantly


over the last 10 years.

The change in female cancer incidence rates over the past ten
years was not statistically significant.

After allowing for differences in age, males were 1.5 times


more likely than females to be diagnosed with cancer.

The majority of new cancer cases were diagnosed in people


aged 60 years and over: 74 per cent of males and 64 per cent
of females.

The marked increase in male incidence rates in 1994 is directly


attributable to an increase in prostate cancer incidence rates in
the same year.
Increasing trend (p<0.05) over years 2000 to 2009.
Decreasing trend (p<0.05) over years 2000 to 2009.
Figure 2a All cancer, ASR*, NSW, 19732009
Trend
ALL CANCER IN NSW: INCIDENCE
Table 7 All cancer statistics, NSW, 2000, 2009
CANCER IN NSW: INCIDENCE REPORT 2009
CANCER INSTITUTE NSW 13
Excludes death certificate only (DCO) cases in 2009. DCO cases are incident cases identified during death certificate processing. For further information refer to Appendix 3.
* Age-standardised rate, standardised to the Australian 2001 population.
** APC is the average annual percent change in ASR* calculated from a log linear model, fitted to rates over the years 2000 to 2009. For further information refer to Appendix 4.
Figure 3b Bladder cancer, new cases by age group, NSW, 2009
Incidence Male Female
All
People
New cases 2009: 539 208 747
New cases 2000: 596 203 799
Percentage of all cancer 2009: 2.5% 1.3% 2.0%
Rank against all cancer 2009: 11 18 15
ASR* per 100,000 2009: 15.2 4.6 9.3
ASR* per 100,000 2000: 21 5.5 12.1
APC** between 2000 and 2009: -4.4% -3.9% -4.1%
Risk of diagnosis by age 85 years
2009:
1 in 47 1 in 150 1 in 74
Median age at diagnosis 2009: 75 78 76
Key Facts

Incidence rates of bladder cancer in both males and females


have decreased significantly over the last 10 years.

After allowing for differences in age, males were 3.3 times


more likely than females to be diagnosed with bladder cancer.

The majority of new cancer cases were diagnosed in people


aged 60 years and over: 88 per cent of males and 89 per cent
of females.

Part of the decline in bladder cancer incidence is artefactual


and due to a change in coding practice that improved the
recording and counting of invasive bladder cancer.
Increasing trend (p<0.05) over years 2000 to 2009.
Decreasing trend (p<0.05) over years 2000 to 2009.
Figure 3a Bladder cancer, ASR*, NSW, 19732009
Trend
BLADDER CANCER IN NSW: INCIDENCE
Table 8 Bladder cancer statistics, NSW, 2000, 2009
CANCER IN NSW: INCIDENCE REPORT 2009
CANCER INSTITUTE NSW 14
Excludes death certificate only (DCO) cases in 2009. DCO cases are incident cases identified during death certificate processing. For further information refer to Appendix 3.
* Age-standardised rate, standardised to the Australian 2001 population.
** APC is the average annual percent change in ASR* calculated from a log linear model, fitted to rates over the years 2000 to 2009. For further information refer to Appendix 4.
Figure 4b Bowel cancer, new cases by age group, NSW, 2009
Incidence Male Female
All
People
New cases 2009: 2,600 2,144 4,744
New cases 2000: 2,366 1,818 4,184
Percentage of all cancer 2009: 12.1% 13.4% 12.6%
Rank against all cancer 2009: 2 2 2
ASR* per 100,000 2009: 71.7 50.9 60.5
ASR* per 100,000 2000: 79.3 50.8 63.6
APC** between 2000 and 2009: -0.3% 0.0% -0.1%
Risk of diagnosis by age 85 years
2009:
1 in 10 1 in 15 1 in 12
Median age at diagnosis 2009: 70 71 71
Key Facts

Bowel cancer incidence ranked second in both males and


females.

One in 10 males and one in 15 females will develop bowel


cancer by the age of 85 years.

Incidence rates of bowel cancer have not changed significantly


over the last 10 years.

After allowing for differences in age, males were 1.4 times


more likely than females to be diagnosed with bowel cancer.

The majority of new bowel cancer cases were diagnosed in


people aged 60 years and over: 78 per cent of males and 78
per cent of females.

More males were diagnosed with bowel cancer than females


consistently across all age categories, except for the 80 years
and over age category.
Increasing trend (p<0.05) over years 2000 to 2009.
Decreasing trend (p<0.05) over years 2000 to 2009.
Figure 4a Bowel cancer, ASR*, NSW, 19732009
Trend
BOWEL CANCER IN NSW: INCIDENCE
Table 9 Bowel cancer statistics, NSW, 2000, 2009
CANCER IN NSW: INCIDENCE REPORT 2009
CANCER INSTITUTE NSW 15
Excludes death certificate only (DCO) cases in 2009. DCO cases are incident cases identified during death certificate processing. For further information refer to Appendix 3.
* Age-standardised rate, standardised to the Australian 2001 population.
** APC is the average annual percent change in ASR* calculated from a log linear model, fitted to rates over the years 2000 to 2009. For further information refer to Appendix 4.
Figure 5b Brain cancer, new cases by age group, NSW, 2009
Incidence Male Female
All
People
New cases 2009: 300 205 505
New cases 2000: 264 176 440
Percentage of all cancer 2009: 1.4% 1.3% 1.3%
Rank against all cancer 2009: 16 19 19
ASR* per 100,000 2009: 8.2 5.3 6.7
ASR* per 100,000 2000: 8.4 5.2 6.7
APC** between 2000 and 2009: -0.5% -0.4% -0.4%
Risk of diagnosis by age 85 years
2009:
1 in 103 1 in 165 1 in 129
Median age at diagnosis 2009: 61 62 61
Key Facts

Incidence rates of brain cancer have not changed significantly


over the last 10 years.

After allowing for differences in age, males were 1.5 times


more likely than females to be diagnosed with brain cancer.

The majority of new brain cancer cases were diagnosed in


people aged between 25 and 70 years: 67 per cent of males
and 56 per cent of females.
Increasing trend (p<0.05) over years 2000 to 2009.
Decreasing trend (p<0.05) over years 2000 to 2009.
Figure 5a Brain cancer, ASR*, NSW, 19732009
Trend
BRAIN CANCER IN NSW: INCIDENCE
Table 10 Brain cancer statistics, NSW, 2000, 2009
CANCER IN NSW: INCIDENCE REPORT 2009
CANCER INSTITUTE NSW 16
Excludes death certificate only (DCO) cases in 2009. DCO cases are incident cases identified during death certificate processing. For further information refer to Appendix 3.
* Age-standardised rate, standardised to the Australian 2001 population.
** APC is the average annual percent change in ASR* calculated from a log linear model, fitted to rates over the years 2000 to 2009. For further information refer to Appendix 4.
Figure 6b Breast cancer, new cases by age group, NSW, 2009
Incidence Male Female
All
People
New cases 2009: 42 4,606 4,648
New cases 2000: 33 3,798 3,831
Percentage of all cancer 2009: 0.2% 28.8% 12.4%
Rank against all cancer 2009: 30 1 3
ASR* per 100,000 2009: 1.1 116.3 60.5
ASR* per 100,000 2000: 1.1 112.7 58.9
APC** between 2000 and 2009: 0.8% -0.2% -0.2%
Risk of diagnosis by age 85 years
2009:
1 in 744 1 in 8 1 in 15
Median age at diagnosis 2009: 66 61 61
Key Facts

Breast cancer incidence ranked first in females and accounted


for 29 per cent of all new cancer diagnoses in females in 2009.

Incidence rates of breast cancer have not changed significantly


over the last 10 years.

One in eight females will develop breast cancer by the age of


85 years.

51 per cent of new breast cancer cases were diagnosed in the


BreastScreen NSW target age group (5069 years), and 74
per cent were diagnosed between 25 and 69.
Increasing trend (p<0.05) over years 2000 to 2009.
Decreasing trend (p<0.05) over years 2000 to 2009.
Figure 6a Breast cancer, ASR*, NSW, 19732009
Trend
BREAST CANCER IN NSW: INCIDENCE
Table 11 Breast cancer statistics, NSW, 2000, 2009
CANCER IN NSW: INCIDENCE REPORT 2009
CANCER INSTITUTE NSW 17
Excludes death certificate only (DCO) cases in 2009. DCO cases are incident cases identified during death certificate processing. For further information refer to Appendix 3.
* Age-standardised rate, standardised to the Australian 2001 population.
** APC is the average annual percent change in ASR* calculated from a log linear model, fitted to rates over the years 2000 to 2009. For further information refer to Appendix 4.
Figure 7b CUP, new cases by age group, NSW, 2009
Incidence Male Female
All
People
New cases 2009: 472 436 908
New cases 2000: 619 603 1,222
Percentage of all cancer 2009: 2.2% 2.7% 2.4%
Rank against all cancer 2009: 12 10 11
ASR* per 100,000 2009: 13.3 9.7 11.3
ASR* per 100,000 2000: 21.4 16.1 18.5
APC** between 2000 and 2009: -6.3% -6.3% -6.3%
Risk of diagnosis by age 85 years
2009:
1 in 56 1 in 79 1 in 67
Median age at diagnosis 2009: 74 77 76
Key Facts

Incidence rates of CUP in both males and females have


decreased significantly over the last 10 years.

After allowing for differences in age, males were 1.4 times


more likely than females to be diagnosed with CUP.

The number of new cases of CUP increased steadily as age


increased.

More males were diagnosed with CUP than females across all
age categories, except for the 80 years and over age category.

Incidence of CUP is likely to be significantly underreported in


2009, due to the missing portion of incidence that comes from
processing death certificate information. For further information
refer to Appendix 3.

CUP includes cancers of other and unspecified sites of:


digestive tract (C26), within respiratory and intrathoracic
organs (C39), retroperitoneum and peritoneum (C48), ill-
defined sites (C76) and unknown primary site (C80). For
further explanation of codes refer to Appendix 2.
Increasing trend (p<0.05) over years 2000 to 2009.
Decreasing trend (p<0.05) over years 2000 to 2009.
Figure 7a CUP, ASR*, NSW, 19732009
Trend
CANCER UNKNOWN PRIMARY (CUP) IN NSW: INCIDENCE
Table 12 CUP statistics, NSW, 2000, 2009
CANCER IN NSW: INCIDENCE REPORT 2009
CANCER INSTITUTE NSW 18
Excludes death certificate only (DCO) cases in 2009. DCO cases are incident cases identified during death certificate processing. For further information refer to Appendix 3.
* Age-standardised rate, standardised to the Australian 2001 population.
** APC is the average annual percent change in ASR* calculated from a log linear model, fitted to rates over the years 2000 to 2009. For further information refer to Appendix 4.
Figure 8b Cervical cancer, new cases by age group, NSW, 2009
Incidence Male Female
All
People
New cases 2009: - 250 -
New cases 2000: - 286 -
Percentage of all cancer 2009: - 1.6% -
Rank against all cancer 2009: - 16 -
ASR* per 100,000 2009: - 6.8 -
ASR* per 100,000 2000: - 8.5 -
APC** between 2000 and 2009: - -1.4% -
Risk of diagnosis by age 85 years
2009:
- 1 in 164 -
Median age at diagnosis 2009: - 48 -
Key Facts

Cervical cancer incidence ranked 16th in females.

Incidence rates of cervical cancer have not changed significantly


over the last 10 years.

50 per cent of new cervical cancer cases were diagnosed in the


2549 year age group, while 82 per cent of cases were
diagnosed in the Cervical Screening Program target age range
of 2069 years of age.

The number of cases diagnosed decreased substantially from


50 years.
Increasing trend (p<0.05) over years 2000 to 2009.
Decreasing trend (p<0.05) over years 2000 to 2009.
Figure 8a Cervical cancer, ASR*, NSW, 19732009
Trend
CERVICAL CANCER IN NSW: INCIDENCE
Table 13 Cervical cancer statistics, NSW, 2000, 2009
CANCER IN NSW: INCIDENCE REPORT 2009
CANCER INSTITUTE NSW 19
Excludes death certificate only (DCO) cases in 2009. DCO cases are incident cases identified during death certificate processing. For further information refer to Appendix 3.
* Age-standardised rate, standardised to the Australian 2001 population.
** APC is the average annual percent change in ASR* calculated from a log linear model, fitted to rates over the years 2000 to 2009. For further information refer to Appendix 4.
Figure 9b Colon cancer, new cases by age group, NSW, 2009
Incidence Male Female
All
People
New cases 2009: 1,526 1,443 2,969
New cases 2000: 1,382 1,250 2,632
Percentage of all cancer 2009: 7.1% 9.0% 7.9%
Rank against all cancer 2009: 5 4 6
ASR* per 100,000 2009: 42.4 33.7 37.7
ASR* per 100,000 2000: 47 34.7 40
APC** between 2000 and 2009: -0.3% -0.3% -0.2%
Risk of diagnosis by age 85 years
2009:
1 in 17 1 in 21 1 in 19
Median age at diagnosis 2009: 71 73 72
Key Facts

Incidence rates of colon cancer have not changed significantly


over the last 10 years.

After allowing for differences in age, males were 1.3 times


more likely than females to be diagnosed with colon cancer.

The majority of new colon cancer cases were diagnosed in


people aged 60 years and over: 82 per cent of males and 84
per cent of females.

Male incidence of colon cancer was greater than female


incidence of colon cancer across most age categories, except
for the 80 years and over age category.

Colon cancer is reported separately as well as combined with


rectal cancer as bowel cancer in this report.
Increasing trend (p<0.05) over years 2000 to 2009.
Decreasing trend (p<0.05) over years 2000 to 2009.
Figure 9a Colon cancer, ASR*, NSW, 19732009
Trend
COLON CANCER IN NSW: INCIDENCE
Table 14 Colon cancer statistics, NSW, 2000, 2009
CANCER IN NSW: INCIDENCE REPORT 2009
CANCER INSTITUTE NSW 20
Excludes death certificate only (DCO) cases in 2009. DCO cases are incident cases identified during death certificate processing. For further information refer to Appendix 3.
* Age-standardised rate, standardised to the Australian 2001 population.
** APC is the average annual percent change in ASR* calculated from a log linear model, fitted to rates over the years 2000 to 2009. For further information refer to Appendix 4.
Figure 10b Head and neck cancer, new cases by age group,
NSW, 2009
Incidence Male Female
All
People
New cases 2009: 744 267 1,011
New cases 2000: 645 238 883
Percentage of all cancer 2009: 3.5% 1.7% 2.7%
Rank against all cancer 2009: 8 15 10
ASR* per 100,000 2009: 20.1 6.7 13.1
ASR* per 100,000 2000: 21 6.7 13.5
APC** between 2000 and 2009: 0.1% -0.3% 0.1%
Risk of diagnosis by age 85 years
2009:
1 in 40 1 in 128 1 in 63
Median age at diagnosis 2009: 64 64 64
Key Facts

Head and neck cancer incidence ranked 8th in males.

Incidence rates of head and neck cancer have not changed


significantly over the last 10 years.

After allowing for differences in age, males were three times


more likely than females to be diagnosed with head and neck
cancer.

Head and neck cancer incidence was considerably higher in


males than females across all age categories.

The majority of new head and neck cancer cases were


diagnosed in people aged 60 years and over: 63 per cent of
males and 60 per cent of females.

Head and neck cancer includes the following: oral (tongue,


mouth, salivary glands), pharynx, larynx and nose, sinuses, etc
(C01-C14, C30-C32). For further explanation of codes refer
to Appendix 2.
Increasing trend (p<0.05) over years 2000 to 2009.
Decreasing trend (p<0.05) over years 2000 to 2009.
Figure 10a Head and neck cancer, ASR*, NSW, 19732009
Trend
HEAD AND NECK CANCER IN NSW: INCIDENCE
Table 15 Head and neck cancer statistics, NSW, 2000, 2009
CANCER IN NSW: INCIDENCE REPORT 2009
CANCER INSTITUTE NSW 21
Excludes death certificate only (DCO) cases in 2009. DCO cases are incident cases identified during death certificate processing. For further information refer to Appendix 3.
* Age-standardised rate, standardised to the Australian 2001 population.
** APC is the average annual percent change in ASR* calculated from a log linear model, fitted to rates over the years 2000 to 2009. For further information refer to Appendix 4.
Figure 11b Kidney cancer, new cases by age group, NSW, 2009
Incidence Male Female
All
People
New cases 2009: 648 389 1,037
New cases 2000: 500 351 851
Percentage of all cancer 2009: 3.0% 2.4% 2.8%
Rank against all cancer 2009: 9 12 9
ASR* per 100,000 2009: 17.7 9.5 13.3
ASR* per 100,000 2000: 16.4 9.8 12.9
APC** between 2000 and 2009: 1.2% -0.6% 0.5%
Risk of diagnosis by age 85 years
2009:
1 in 45 1 in 79 1 in 58
Median age at diagnosis 2009: 66 68 67
Key Facts

Incidence rates of kidney cancer have not changed significantly


over the last 10 years.

After allowing for differences in age, males were almost two


times more likely than females to be diagnosed with kidney
cancer.

The majority of new kidney cancer cases were diagnosed in


people aged 60 years and over: 69 per cent of males and 73
per cent of females.
Increasing trend (p<0.05) over years 2000 to 2009.
Decreasing trend (p<0.05) over years 2000 to 2009.
Figure 11a Kidney cancer, ASR*, NSW, 19732009
Trend
KIDNEY CANCER IN NSW: INCIDENCE
Table 16 Kidney cancer statistics, NSW, 2000, 2009
CANCER IN NSW: INCIDENCE REPORT 2009
CANCER INSTITUTE NSW 22
Excludes death certificate only (DCO) cases in 2009. DCO cases are incident cases identified during death certificate processing. For further information refer to Appendix 3.
* Age-standardised rate, standardised to the Australian 2001 population.
** APC is the average annual percent change in ASR* calculated from a log linear model, fitted to rates over the years 2000 to 2009. For further information refer to Appendix 4.
Figure 12b Leukaemia, new cases by age group, NSW, 2009
Incidence Male Female
All
People
New cases 2009: 540 356 896
New cases 2000: 548 356 904
Percentage of all cancer 2009: 2.5% 2.2% 2.4%
Rank against all cancer 2009: 10 14 12
ASR* per 100,000 2009: 15.1 8.7 11.6
ASR* per 100,000 2000: 18.4 10 13.8
APC** between 2000 and 2009: -2.6% -2.3% -2.5%
Risk of diagnosis by age 85 years
2009:
1 in 54 1 in 93 1 in 69
Median age at diagnosis 2009: 67 67 67
Key Facts

Incidence rates of leukaemia have decreased signficantly in both


males and females over the past 10 years.

Among children, leukaemia was the most common cancer in


both boys and girls aged under 15 years.

After allowing for differences in age, males were 1.7 times


more likely than females to be diagnosed with leukaemia.

The majority of new leukaemia cases were diagnosed in people


aged 60 years and over: 65 per cent of males and 66 per cent
of females.
Increasing trend (p<0.05) over years 2000 to 2009.
Decreasing trend (p<0.05) over years 2000 to 2009.
Figure 12a Leukaemia, ASR*, NSW, 19732009
Trend
LEUKAEMIA IN NSW: INCIDENCE
Table 17 Leukaemia statistics, NSW, 2000, 2009
CANCER IN NSW: INCIDENCE REPORT 2009
CANCER INSTITUTE NSW 23
Excludes death certificate only (DCO) cases in 2009. DCO cases are incident cases identified during death certificate processing. For further information refer to Appendix 3.
* Age-standardised rate, standardised to the Australian 2001 population.
** APC is the average annual percent change in ASR* calculated from a log linear model, fitted to rates over the years 2000 to 2009. For further information refer to Appendix 4.
Figure 13b Lip cancer, new cases by age group, NSW, 2009
Incidence Male Female
All
People
New cases 2009: 200 72 272
New cases 2000: 185 71 256
Percentage of all cancer 2009: 0.9% 0.5% 0.7%
Rank against all cancer 2009: 20 28 24
ASR* per 100,000 2009: 5.6 1.7 3.6
ASR* per 100,000 2000: 6.1 1.9 3.9
APC** between 2000 and 2009: -1.2% -1.3% -1.1%
Risk of diagnosis by age 85 years
2009:
1 in 153 1 in 528 1 in 244
Median age at diagnosis 2009: 61 68 63
Key Facts

Incidence rates of lip cancer have not changed significantly over


the last 10 years.

After allowing for differences in age, males were 3.3 times


more likely than females to be diagnosed with lip cancer.

The majority of new lip cancer cases were diagnosed in people


aged 60 years and over: 70 per cent of males and 51 per cent
of females.

Lip cancer excludes skin of lip. Skin of lip has been coded to
skin neoplasms.
Increasing trend (p<0.05) over years 2000 to 2009.
Decreasing trend (p<0.05) over years 2000 to 2009.
Figure 13a Lip cancer, ASR*, NSW, 19732009
Trend
LIP CANCER IN NSW: INCIDENCE
Table 18 Lip cancer statistics, NSW, 2000, 2009
CANCER IN NSW: INCIDENCE REPORT 2009
CANCER INSTITUTE NSW 24
Excludes death certificate only (DCO) cases in 2009. DCO cases are incident cases identified during death certificate processing. For further information refer to Appendix 3.
* Age-standardised rate, standardised to the Australian 2001 population.
** APC is the average annual percent change in ASR* calculated from a log linear model, fitted to rates over the years 2000 to 2009. For further information refer to Appendix 4.
Figure 14b Liver cancer, new cases by age group, NSW, 2009
Incidence Male Female
All
People
New cases 2009: 367 140 507
New cases 2000: 194 70 264
Percentage of all cancer 2009: 1.7% 0.9% 1.4%
Rank against all cancer 2009: 15 21 18
ASR* per 100,000 2009: 10.1 3.3 6.6
ASR* per 100,000 2000: 6.3 2 4
APC** between 2000 and 2009: 4.3% 4.8% 4.6%
Risk of diagnosis by age 85 years
2009:
1 in 74 1 in 221 1 in 114
Median age at diagnosis 2009: 66 70 67
Key Facts

Incidence rates of liver cancer have increased significantly over


the last 10 years.

After allowing for differences in age, males were 3.1 times


more likely than females to be diagnosed with liver cancer.

The majority of new liver cancer cases were diagnosed in


people aged 50 years and over: 90 per cent of males and 89
per cent of females.

The increase in 2009 is likely to be somewhat underreported,


particularly in males, due to the missing portion of incidence
that comes from processing death certificate information. For
further information refer to Appendix 3.
Increasing trend (p<0.05) over years 2000 to 2009.
Decreasing trend (p<0.05) over years 2000 to 2009.
Figure 14a Liver cancer, ASR*, NSW, 19732009
Trend
LIVER CANCER IN NSW: INCIDENCE
Table 19 Liver cancer statistics, NSW, 2000, 2009
CANCER IN NSW: INCIDENCE REPORT 2009
CANCER INSTITUTE NSW 25
Excludes death certificate only (DCO) cases in 2009. DCO cases are incident cases identified during death certificate processing. For further information refer to Appendix 3.
* Age-standardised rate, standardised to the Australian 2001 population.
** APC is the average annual percent change in ASR* calculated from a log linear model, fitted to rates over the years 2000 to 2009. For further information refer to Appendix 4.
Figure 15b Lung cancer, new cases by age group, NSW, 2009
Incidence Male Female
All
People
New cases 2009: 1,991 1,348 3,339
New cases 2000: 1,861 966 2,827
Percentage of all cancer 2009: 9.2% 8.4% 8.9%
Rank against all cancer 2009: 4 5 5
ASR* per 100,000 2009: 54.9 32.2 42.3
ASR* per 100,000 2000: 62.9 27.3 42.8
APC** between 2000 and 2009: -1.1% 2.6% 0.4%
Risk of diagnosis by age 85 years
2009:
1 in 13 1 in 22 1 in 17
Median age at diagnosis 2009: 71 70 70
Key Facts

Incidence rates of lung cancer have increased significantly in


females and decreased significantly in males over the last 10
years.

After allowing for differences in age, males were 1.7 times


more likely than females to be diagnosed with lung cancer.

The majority of new lung cancer cases were diagnosed in


people aged 60 years and over: 83 per cent of males and 80
per cent of females.

Incidence in 2009 is likely to be somewhat underreported, due


to the missing portion of incidence that comes from processing
death certificate information. For further information refer to
Appendix 3.
Increasing trend (p<0.05) over years 2000 to 2009.
Decreasing trend (p<0.05) over years 2000 to 2009.
Figure 15a Lung cancer, ASR*, NSW, 19732009
Trend
LUNG CANCER IN NSW: INCIDENCE
Table 20 Lung cancer statistics, NSW, 2000, 2009
CANCER IN NSW: INCIDENCE REPORT 2009
CANCER INSTITUTE NSW 26
Excludes death certificate only (DCO) cases in 2009. DCO cases are incident cases identified during death certificate processing. For further information refer to Appendix 3.
* Age-standardised rate, standardised to the Australian 2001 population.
** APC is the average annual percent change in ASR* calculated from a log linear model, fitted to rates over the years 2000 to 2009. For further information refer to Appendix 4.
Figure 16b Melanoma, new cases by age group, NSW, 2009
Incidence Male Female
All
People
New cases 2009: 2,178 1,527 3,705
New cases 2000: 1,641 1,186 2,827
Percentage of all cancer 2009: 10.1% 9.5% 9.9%
Rank against all cancer 2009: 3 3 4
ASR* per 100,000 2009: 60.1 38.3 48.2
ASR* per 100,000 2000: 53.7 34.8 43.2
APC** between 2000 and 2009: 1.0% 0.6% 0.9%
Risk of diagnosis by age 85 years
2009:
1 in 14 1 in 24 1 in 18
Median age at diagnosis 2009: 65 62 64
Key Facts

Incidence rates of melanoma have not changed significantly


over the last 10 years.

Melanoma incidence ranked third in both males and females.

After allowing for differences in age, males were 1.6 times


more likely than females to be diagnosed with melanoma.

The majority of new melanoma cases were diagnosed in


people aged 60 years and over: 64 per cent of males and 55
per cent of females.

More females than males were diagnosed with melanoma in


the 15 to 49 year age category, but the trend reversed from 50
years onwards.

Refers to invasive melanoma of the skin only.


Increasing trend (p<0.05) over years 2000 to 2009.
Decreasing trend (p<0.05) over years 2000 to 2009.
Figure 16a Melanoma, ASR*, NSW, 19732009
Trend
MELANOMA IN NSW: INCIDENCE
Table 21 Melanoma statistics, NSW, 2000, 2009
CANCER IN NSW: INCIDENCE REPORT 2009
CANCER INSTITUTE NSW 27
Excludes death certificate only (DCO) cases in 2009. DCO cases are incident cases identified during death certificate processing. For further information refer to Appendix 3.
* Age-standardised rate, standardised to the Australian 2001 population.
** APC is the average annual percent change in ASR* calculated from a log linear model, fitted to rates over the years 2000 to 2009. For further information refer to Appendix 4.
Figure 17b Mesothelioma, new cases by age group, NSW, 2009
Incidence Male Female
All
People
New cases 2009: 184 42 226
New cases 2000: 135 26 161
Percentage of all cancer 2009: 0.9% 0.3% 0.6%
Rank against all cancer 2009: 23 31 28
ASR* per 100,000 2009: 5.1 0.9 2.8
ASR* per 100,000 2000: 4.5 0.7 2.4
APC** between 2000 and 2009: 1.2% 0.4% 1.0%
Risk of diagnosis by age 85 years
2009:
1 in 123 1 in 672 1 in 219
Median age at diagnosis 2009: 73 79 74
Key Facts

Incidence rates of mesothelioma have not changed significantly


over the last 10 years.

Males were 5.7 times more likely than females to be diagnosed


with mesothelioma.

The majority of new mesothelioma cases were diagnosed in


people aged 60 years and over: 92 per cent of males and 86
per cent of females.
Increasing trend (p<0.05) over years 2000 to 2009.
Decreasing trend (p<0.05) over years 2000 to 2009.
Figure 17a Mesothelioma, ASR*, NSW, 19732009
Trend
MESOTHELIOMA IN NSW: INCIDENCE
Table 22 Mesothelioma statistics, NSW, 2000, 2009
CANCER IN NSW: INCIDENCE REPORT 2009
CANCER INSTITUTE NSW 28
Excludes death certificate only (DCO) cases in 2009. DCO cases are incident cases identified during death certificate processing. For further information refer to Appendix 3.
* Age-standardised rate, standardised to the Australian 2001 population.
** APC is the average annual percent change in ASR* calculated from a log linear model, fitted to rates over the years 2000 to 2009. For further information refer to Appendix 4.
Figure 18b Multiple myeloma, new cases by age group, NSW,
2009
Incidence Male Female
All
People
New cases 2009: 266 170 436
New cases 2000: 198 199 397
Percentage of all cancer 2009: 1.2% 1.1% 1.2%
Rank against all cancer 2009: 18 20 20
ASR* per 100,000 2009: 7.3 4 5.5
ASR* per 100,000 2000: 6.8 5.5 6
APC** between 2000 and 2009: -1.1% -2.2% -1.5%
Median age at diagnosis 2009: 69 71 70
Key Facts

Incidence rates of multiple myeloma have not changed


significantly in males and females over the last 10 years, but
there has been a significant decrease in all people.

After allowing for differences in age, males were 1.8 times


more likely than females to be diagnosed with multiple
myeloma.

The majority of new multiple myeloma cases were diagnosed


in people aged 60 years and over: 75 per cent of males and 82
per cent of females.
Increasing trend (p<0.05) over years 2000 to 2009.
Decreasing trend (p<0.05) over years 2000 to 2009.
Figure 18a Multiple myeloma, ASR*, NSW, 19732009
Trend
MULTIPLE MYELOMA IN NSW: INCIDENCE
Table 23 Multiple myeloma statistics, NSW, 2000, 2009
CANCER IN NSW: INCIDENCE REPORT 2009
CANCER INSTITUTE NSW 29
Excludes death certificate only (DCO) cases in 2009. DCO cases are incident cases identified during death certificate processing. For further information refer to Appendix 3.
* Age-standardised rate, standardised to the Australian 2001 population.
** APC is the average annual percent change in ASR* calculated from a log linear model, fitted to rates over the years 2000 to 2009. For further information refer to Appendix 4.
Figure 19b Myelodysplasia, new cases by age group, NSW, 2009
Incidence Male Female
All
People
New cases 2009: 187 138 325
New cases 2000: 0 0 0
Percentage of all cancer 2009: 0.9% 0.9% 0.9%
Rank against all cancer 2009: 22 22 23
ASR* per 100,000 2009: 5.5 3.1 4
ASR* per 100,000 2000: - - -
APC** between 2000 and 2009: - - -
Risk of diagnosis by age 85 years
2009:
1 in 147 1 in 223 1 in 181
Median age at diagnosis 2009: 79 78 78
Key Facts

Prior to 2003, myelodysplasia was classified as unknown


behaviour and was reclassified in 2003 as an invasive cancer.

After allowing for differences in age, males were 1.8 times


more likely than females to be diagnosed with myelodysplasia.

The majority of new myelodysplasia cases were diagnosed in


people aged 70 years and over: 79 per cent of males and 77
per cent of females.
Increasing trend (p<0.05) over years 2000 to 2009.
Decreasing trend (p<0.05) over years 2000 to 2009.
Figure 19a Myelodysplasia, ASR*, NSW, 19732009
Trend
MYELODYSPLASIA IN NSW: INCIDENCE
Table 24 Myelodysplasia statistics, NSW, 2000, 2009
CANCER IN NSW: INCIDENCE REPORT 2009
CANCER INSTITUTE NSW 30
Excludes death certificate only (DCO) cases in 2009. DCO cases are incident cases identified during death certificate processing. For further information refer to Appendix 3.
* Age-standardised rate, standardised to the Australian 2001 population.
** APC is the average annual percent change in ASR* calculated from a log linear model, fitted to rates over the years 2000 to 2009. For further information refer to Appendix 4.
Figure 20b Non-Hodgkin's lymphoma, new cases by age group,
NSW, 2009
Incidence Male Female
All
People
New cases 2009: 760 618 1,378
New cases 2000: 657 584 1,241
Percentage of all cancer 2009: 3.5% 3.9% 3.7%
Rank against all cancer 2009: 7 8 8
ASR* per 100,000 2009: 21 14.9 17.8
ASR* per 100,000 2000: 21.9 16.4 18.9
APC** between 2000 and 2009: -0.3% -0.2% -0.2%
Risk of diagnosis by age 85 years
2009:
1 in 38 1 in 52 1 in 44
Median age at diagnosis 2009: 66 68 66
Key Facts

Incidence rates of NHL have not changed significantly over the


last 10 years.

After allowing for differences in age, males were 1.4 times


more likely than females to be diagnosed with NHL.

The majority of new cases of NHL were diagnosed in people


aged 60 years and over: 66 per cent of males and 69 per cent
of females.

More males were diagnosed with NHL than females across all
age categories, except the 80 years and over age category.
Increasing trend (p<0.05) over years 2000 to 2009.
Decreasing trend (p<0.05) over years 2000 to 2009.
Figure 20a Non-Hodgkin's lymphoma, ASR*, NSW, 19732009
Trend
NON-HODGKIN'S LYMPHOMA (NHL) IN NSW: INCIDENCE
Table 25 Non-Hodgkin's lymphoma statistics, NSW, 2000, 2009
CANCER IN NSW: INCIDENCE REPORT 2009
CANCER INSTITUTE NSW 31
Excludes death certificate only (DCO) cases in 2009. DCO cases are incident cases identified during death certificate processing. For further information refer to Appendix 3.
* Age-standardised rate, standardised to the Australian 2001 population.
** APC is the average annual percent change in ASR* calculated from a log linear model, fitted to rates over the years 2000 to 2009. For further information refer to Appendix 4.
Figure 21b Oesophageal cancer, new cases by age group, NSW,
2009
Incidence Male Female
All
People
New cases 2009: 278 126 404
New cases 2000: 216 121 337
Percentage of all cancer 2009: 1.3% 0.8% 1.1%
Rank against all cancer 2009: 17 24 21
ASR* per 100,000 2009: 7.6 2.8 5.1
ASR* per 100,000 2000: 7.2 3.2 5.1
APC** between 2000 and 2009: 1.1% -1.8% 0.2%
Risk of diagnosis by age 85 years
2009:
1 in 99 1 in 271 1 in 149
Median age at diagnosis 2009: 69 75 71
Key Facts

Incidence rates of oesophageal cancer in females have


decreased significantly over the last 10 years, but there has
been no significant change in incidence rates in males.

After allowing for differences in age, males were 2.7 times


more likely than females to be diagnosed with oesophageal
cancer.

The majority of new oesophageal cancer cases were diagnosed


in people aged 60 years and over: 75 per cent of males and 92
per cent of females.

More males were diagnosed with oesophageal cancer than


females across all age categories, except the 80 years and over
age category, where there were marginally more females
diagnosed.
Increasing trend (p<0.05) over years 2000 to 2009.
Decreasing trend (p<0.05) over years 2000 to 2009.
Figure 21a Oesophageal cancer, ASR*, NSW, 19732009
Trend
OESOPHAGEAL CANCER IN NSW: INCIDENCE
Table 26 Oesophageal cancer statistics, NSW, 2000, 2009
CANCER IN NSW: INCIDENCE REPORT 2009
CANCER INSTITUTE NSW 32
Excludes death certificate only (DCO) cases in 2009. DCO cases are incident cases identified during death certificate processing. For further information refer to Appendix 3.
* Age-standardised rate, standardised to the Australian 2001 population.
** APC is the average annual percent change in ASR* calculated from a log linear model, fitted to rates over the years 2000 to 2009. For further information refer to Appendix 4.
Figure 22b Ovarian cancer, new cases by age group, NSW, 2009
Incidence Male Female
All
People
New cases 2009: - 395 -
New cases 2000: - 389 -
Percentage of all cancer 2009: - 2.5% -
Rank against all cancer 2009: - 11 -
ASR* per 100,000 2009: - 9.8 -
ASR* per 100,000 2000: - 11.2 -
APC** between 2000 and 2009: - -0.7% -
Risk of diagnosis by age 85 years
2009:
- 1 in 87 -
Median age at diagnosis 2009: - 63 -
Key Facts

Incidence rates of ovarian cancer have not changed significantly


over the last 10 years.

The majority of new ovarian cancer cases were diagnosed in


women aged 60 years and over (61 per cent).

Incidence of ovarian cancer peaked in the 6069 year age


group.
Increasing trend (p<0.05) over years 2000 to 2009.
Decreasing trend (p<0.05) over years 2000 to 2009.
Figure 22a Ovarian cancer, ASR*, NSW, 19732009
Trend
OVARIAN CANCER IN NSW: INCIDENCE
Table 27 Ovarian cancer statistics, NSW, 2000, 2009
CANCER IN NSW: INCIDENCE REPORT 2009
CANCER INSTITUTE NSW 33
Excludes death certificate only (DCO) cases in 2009. DCO cases are incident cases identified during death certificate processing. For further information refer to Appendix 3.
* Age-standardised rate, standardised to the Australian 2001 population.
** APC is the average annual percent change in ASR* calculated from a log linear model, fitted to rates over the years 2000 to 2009. For further information refer to Appendix 4.
Figure 23b Pancreatic cancer, new cases by age group, NSW,
2009
Incidence Male Female
All
People
New cases 2009: 444 388 832
New cases 2000: 285 323 608
Percentage of all cancer 2009: 2.1% 2.4% 2.2%
Rank against all cancer 2009: 13 13 13
ASR* per 100,000 2009: 12.3 9 10.5
ASR* per 100,000 2000: 9.8 8.7 9.2
APC** between 2000 and 2009: 2.4% 1.8% 2.2%
Risk of diagnosis by age 85 years
2009:
1 in 57 1 in 76 1 in 66
Median age at diagnosis 2009: 72 74 73
Key Facts

Incidence rates of pancreatic cancer in both males and females


have increased significantly over the last 10 years.

After allowing for differences in age, males were 1.4 times


more likely than females to be diagnosed with pancreatic
cancer.

The majority of new pancreatic cancer cases were diagnosed in


people aged 60 years and over: 81 per cent of males and 87
per cent of females.

More males were diagnosed with pancreatic cancer than


females across all age categories, except for the 80 years and
over age category, where there were marginally more females.

The increase in 2009 is likely to be somewhat underreported


due to the missing portion of incidence that comes from
processing death certificate information. For further information
refer to Appendix 3.
Increasing trend (p<0.05) over years 2000 to 2009.
Decreasing trend (p<0.05) over years 2000 to 2009.
Figure 23a Pancreatic cancer, ASR*, NSW, 19732009
Trend
PANCREATIC CANCER IN NSW: INCIDENCE
Table 28 Pancreatic cancer statistics, NSW, 2000, 2009
CANCER IN NSW: INCIDENCE REPORT 2009
CANCER INSTITUTE NSW 34
Excludes death certificate only (DCO) cases in 2009. DCO cases are incident cases identified during death certificate processing. For further information refer to Appendix 3.
* Age-standardised rate, standardised to the Australian 2001 population.
** APC is the average annual percent change in ASR* calculated from a log linear model, fitted to rates over the years 2000 to 2009. For further information refer to Appendix 4.
Figure 24b Prostate cancer, new cases by age group, NSW,
2009
Incidence Male Female
All
People
New cases 2009: 7,277 - -
New cases 2000: 3,892 - -
Percentage of all cancer 2009: 33.8% - -
Rank against all cancer 2009: 1 - -
ASR* per 100,000 2009: 194.1 - -
ASR* per 100,000 2000: 131.5 - -
APC** between 2000 and 2009: 5.3% - -
Risk of diagnosis by age 85 years
2009:
1 in 4 - -
Median age at diagnosis 2009: 67 - -
Key Facts

Prostate cancer incidence ranked first in males and accounted


for 34 per cent of all new cancer cases in males in 2009.

Incidence rates of prostate cancer have increased significantly


over the last 10 years.

The majority of new prostate cancer cases were diagnosed in


males aged 60 years and over (80 per cent).
Increasing trend (p<0.05) over years 2000 to 2009.
Decreasing trend (p<0.05) over years 2000 to 2009.
Figure 24a Prostate cancer, ASR*, NSW, 19732009
Trend
PROSTATE CANCER IN NSW: INCIDENCE
Table 29 Prostate cancer statistics, NSW, 2000, 2009
CANCER IN NSW: INCIDENCE REPORT 2009
CANCER INSTITUTE NSW 35
Excludes death certificate only (DCO) cases in 2009. DCO cases are incident cases identified during death certificate processing. For further information refer to Appendix 3.
* Age-standardised rate, standardised to the Australian 2001 population.
** APC is the average annual percent change in ASR* calculated from a log linear model, fitted to rates over the years 2000 to 2009. For further information refer to Appendix 4.
Figure 25b Rectal cancer, new cases by age group, NSW, 2009
Incidence Male Female
All
People
New cases 2009: 1,074 701 1,775
New cases 2000: 984 568 1,552
Percentage of all cancer 2009: 5.0% 4.4% 4.7%
Rank against all cancer 2009: 6 6 7
ASR* per 100,000 2009: 29.4 17.1 22.8
ASR* per 100,000 2000: 32.4 16.1 23.6
APC** between 2000 and 2009: -0.4% 0.6% 0.0%
Risk of diagnosis by age 85 years
2009:
1 in 26 1 in 46 1 in 34
Median age at diagnosis 2009: 67 66 67
Key Facts

Rectal cancer incidence ranked sixth in both males and females.

Incidence rates of rectal cancer have not changed significantly


over the last 10 years.

Allowing for differences in age, males were 1.7 times more


likely to be diagnosed with rectal cancer than females.

The majority of new rectal cancer cases were diagnosed in


people aged 60 years and over: 72 per cent of males and 67
per cent of females.
Increasing trend (p<0.05) over years 2000 to 2009.
Decreasing trend (p<0.05) over years 2000 to 2009.
Figure 25a Rectal cancer, ASR*, NSW, 19732009
Trend
RECTAL CANCER IN NSW: INCIDENCE
Table 30 Rectal cancer statistics, NSW, 2000, 2009
CANCER IN NSW: INCIDENCE REPORT 2009
CANCER INSTITUTE NSW 36
Excludes death certificate only (DCO) cases in 2009. DCO cases are incident cases identified during death certificate processing. For further information refer to Appendix 3.
* Age-standardised rate, standardised to the Australian 2001 population.
** APC is the average annual percent change in ASR* calculated from a log linear model, fitted to rates over the years 2000 to 2009. For further information refer to Appendix 4.
Figure 26b Stomach cancer, new cases by age group, NSW,
2009
Incidence Male Female
All
People
New cases 2009: 430 222 652
New cases 2000: 416 225 641
Percentage of all cancer 2009: 2.0% 1.4% 1.7%
Rank against all cancer 2009: 14 17 17
ASR* per 100,000 2009: 11.8 5.2 8.3
ASR* per 100,000 2000: 14.5 6.2 9.7
APC** between 2000 and 2009: -2.0% -1.3% -1.6%
Risk of diagnosis by age 85 years
2009:
1 in 61 1 in 146 1 in 89
Median age at diagnosis 2009: 70 73 70
Key Facts

Incidence rates of stomach cancer have decreased significantly


in both males and females over the last 10 years.

Allowing for differences in age, males were 2.3 times more


likely to be diagnosed with stomach cancer than females.

The majority of new stomach cancer cases were diagnosed in


people aged 60 years and over: 78 per cent of males and 69
per cent of females.
Increasing trend (p<0.05) over years 2000 to 2009.
Decreasing trend (p<0.05) over years 2000 to 2009.
Figure 26a Stomach cancer, ASR*, NSW, 19732009
Trend
STOMACH CANCER IN NSW: INCIDENCE
Table 31 Stomach cancer statistics, NSW, 2000, 2009
CANCER IN NSW: INCIDENCE REPORT 2009
CANCER INSTITUTE NSW 37
Excludes death certificate only (DCO) cases in 2009. DCO cases are incident cases identified during death certificate processing. For further information refer to Appendix 3.
* Age-standardised rate, standardised to the Australian 2001 population.
** APC is the average annual percent change in ASR* calculated from a log linear model, fitted to rates over the years 2000 to 2009. For further information refer to Appendix 4.
Figure 27b Testicular cancer, new cases by age group, NSW,
2009
Incidence Male Female
All
People
New cases 2009: 227 - -
New cases 2000: 204 - -
Percentage of all cancer 2009: 1.1% - -
Rank against all cancer 2009: 19 - -
ASR* per 100,000 2009: 6.6 - -
ASR* per 100,000 2000: 6.3 - -
APC** between 2000 and 2009: -0.3% - -
Risk of diagnosis by age 85 years
2009:
1 in 216 - -
Median age at diagnosis 2009: 35 - -
Key Facts

Incidence rates of testicular cancer have not changed


significantly over the last 10 years.

The majority of testicular cancer cases occured in males under


50 years of age: 93 per cent.

The median age at diagnosis of 35 years was


uncharacteristically low compared to other cancers.

Unlike most other cancers, the incidence of testicular cancer


peaked in the 2549 year age group, with most cases
occurring in the 3539 year age category.
Increasing trend (p<0.05) over years 2000 to 2009.
Decreasing trend (p<0.05) over years 2000 to 2009.
Figure 27a Testicular cancer, ASR*, NSW, 19732009
Trend
TESTICULAR CANCER IN NSW: INCIDENCE
Table 32 Testicular cancer statistics, NSW, 2000, 2009
CANCER IN NSW: INCIDENCE REPORT 2009
CANCER INSTITUTE NSW 38
Excludes death certificate only (DCO) cases in 2009. DCO cases are incident cases identified during death certificate processing. For further information refer to Appendix 3.
* Age-standardised rate, standardised to the Australian 2001 population.
** APC is the average annual percent change in ASR* calculated from a log linear model, fitted to rates over the years 2000 to 2009. For further information refer to Appendix 4.
Figure 28b Thyroid cancer, new cases by age group, NSW, 2009
Incidence Male Female
All
People
New cases 2009: 195 583 778
New cases 2000: 98 303 401
Percentage of all cancer 2009: 0.9% 3.6% 2.1%
Rank against all cancer 2009: 21 9 14
ASR* per 100,000 2009: 5.4 15.9 10.7
ASR* per 100,000 2000: 3.1 9.2 6.2
APC** between 2000 and 2009: 6.7% 6.0% 6.2%
Risk of diagnosis by age 85 years
2009:
1 in 187 1 in 70 1 in 101
Median age at diagnosis 2009: 51 50 50
Key Facts

Incidence rates of thyroid cancer have increased significantly in


both males and females over the last 10 years.

Allowing for differences in age, females were 2.9 times more


likely to be diagnosed with thyroid cancer than males.

Unlike most other cancers, the incidence of thyroid cancer


peaked in the 2549 year age group in both males and
females.

The majority of new thyroid cancer cases were diagnosed in


people aged between 25 and 59 years: 67 per cent of females
and 66 per cent of males.

The median age at diagnosis is lower than most other cancers,


apart from testicular cancer in males: 50 years in males and 51
years in females.
Increasing trend (p<0.05) over years 2000 to 2009.
Decreasing trend (p<0.05) over years 2000 to 2009.
Figure 28a Thyroid cancer, ASR*, NSW, 19732009
Trend
THYROID CANCER IN NSW: INCIDENCE
Table 33 Thyroid cancer statistics, NSW, 2000, 2009
CANCER IN NSW: INCIDENCE REPORT 2009
CANCER INSTITUTE NSW 39
Excludes death certificate only (DCO) cases in 2009. DCO cases are incident cases identified during death certificate processing. For further information refer to Appendix 3.
* Age-standardised rate, standardised to the Australian 2001 population.
** APC is the average annual percent change in ASR* calculated from a log linear model, fitted to rates over the years 2000 to 2009. For further information refer to Appendix 4.
Figure 29b Uterine cancer, new cases by age group, NSW, 2009
Incidence Male Female
All
People
New cases 2009: - 685 -
New cases 2000: - 498 -
Percentage of all cancer 2009: - 4.3% -
Rank against all cancer 2009: - 7 -
ASR* per 100,000 2009: - 16.8 -
ASR* per 100,000 2000: - 14.4 -
APC** between 2000 and 2009: - 1.9% -
Risk of diagnosis by age 85 years
2009:
- 1 in 50 -
Median age at diagnosis 2009: - 63 -
Key Facts

Incidence rates of uterine cancer have increased significantly


over the last 10 years.

Uterine cancer accounted for 4.3 per cent of all cancers in


females in 2009 and ranked seventh for incidence.

The majority of new uterine cases were diagnosed in females


aged over 60 years (63 per cent).
Increasing trend (p<0.05) over years 2000 to 2009.
Decreasing trend (p<0.05) over years 2000 to 2009.
Figure 29a Uterine cancer, ASR*, NSW, 19732009
Trend
UTERINE CANCER IN NSW: INCIDENCE
Table 34 Uterine cancer statistics, NSW, 2000, 2009
CANCER IN NSW: INCIDENCE REPORT 2009
CANCER INSTITUTE NSW 40
KEY FACTS

The classification for cancer in children (014 years)


used in this report is based on morphology and site,
with an emphasis on morphology*, as opposed to the
emphasis of site on adults.

In 20052009 there were 922 new childhood cancer


cases (498 in males, 424 in females).

More than half of childhood cancers in 20052009


were leukaemia, and cancers of the brain and central
nervous system.
CANCER IN NSW: INCIDENCE REPORT 2009
CHILDHOOD CANCER IN NSW: INCIDENCE
Childhood Rate Male Childhood Rate Female
All cancers All cancers
Central nervous system Central nervous system
Leukaemias Leukaemias
Figure 30a Childhood cancer incidence (<15 years), NSW, 20052009
Figure 30b Trends in childhood cancer, NSW, 19752009
KEY FACTS

In the period 19751979, the age-standardised


incidence rates were 14.1 new cases per 100,000 males
and 12.4 per 100,000 females.

By 20052009 this increased to 14.9 per 100,000


males and 13.7 per 100,000 females.

Incidence rates of childhood leukaemia increased from


4.9 per 100,000 (all children) in 19751979, to 5.9 per
100,000 males and 5.5 per 100,000 females in 2005
2009.

Incidence rates of childhood central nervous system


cancers were 3.0 per 100,000 males and 2.3 per
100,000 females in 19751979.

This decreased by 20052009 to 2.0 per 100,000


males and 1.8 per 100,000 females.
* International Classification of Childhood Cancer. IARC Technical Report No. 29 - Kramarova E, Stiller CA, Ferlay J at el. Lyon: International Agency for Research on Cancer, 1996.
CANCER INSTITUTE NSW 41
CANCER IN NSW: INCIDENCE REPORT 2009
Table 35 Childhood cancer by age group, NSW, 20052009
CHILDHOOD CANCER IN NSW: INCIDENCE
04 59 1014 014
Cancer Type Sex n
Age-
Specific
Rate
n
Age-
Specific
Rate
n
Age-
Specific
Rate
n ASR*
All cancers Males
225 19.8 120 10.7 153 13.2 498 14.9
Females
225 21.0 91 8.5 108 9.8 424 13.7
Astrocytoma Males
7 0.6 7 0.6 5 0.4 19 0.6
Females
13 1.2 3 0.3 5 0.5 21 0.7
Ewing's sarcoma Males
1 0.1 4 0.4 8 0.7 13 0.3
Females
1 0.1 4 0.4 3 0.3 8 0.2
Gonadal germ cell Males
2 0.2 0 0.0 1 0.1 3 0.1
Females
0 0.0 2 0.2 5 0.5 7 0.2
Hepatoblastoma Males
9 0.8 0 0.0 0 0.0 9 0.3
Females
4 0.4 0 0.0 0 0.0 4 0.1
Hodgkin's disease Males
1 0.1 8 0.7 15 1.3 24 0.6
Females
0 0.0 1 0.1 17 1.5 18 0.5
Lymphoid leukaemia Males
79 7.0 38 3.4 43 3.7 160 4.9
Females
73 6.8 35 3.3 14 1.3 122 4.1
Malignant epithelial Males
0 0.0 2 0.2 10 0.9 12 0.3
Females
1 0.1 5 0.5 13 1.2 19 0.5
Malignant melanoma Males
0 0.0 1 0.1 2 0.2 3 0.1
Females
0 0.0 4 0.4 4 0.4 8 0.2
Neuroblastoma and ganglioneuroblastoma Males
42 3.7 6 0.5 0 0.0 48 1.6
Females
31 2.9 1 0.1 1 0.1 33 1.2
Non-gonadal germ cell Males
7 0.6 0 0.0 1 0.1 8 0.3
Females
5 0.5 1 0.1 0 0.0 6 0.2
Non-Hodgkin's lymphoma Males
5 0.4 18 1.6 18 1.6 41 1.1
Females
3 0.3 5 0.5 8 0.7 16 0.5
Osteosarcoma Males
0 0.0 1 0.1 7 0.6 8 0.2
Females
1 0.1 0 0.0 5 0.5 6 0.2
Other Males
14 1.2 1 0.1 4 0.3 19 0.6
Females
15 1.4 3 0.3 4 0.4 22 0.7
Other acute leukaemia Males
12 1.1 2 0.2 10 0.9 24 0.7
Females
20 1.9 4 0.4 8 0.7 32 1.1
Other and unspecified leukaemia Males
3 0.3 4 0.4 3 0.3 10 0.3
Females
4 0.4 5 0.5 3 0.3 12 0.4
Other germ cell and gonadal Males
0 0.0 3 0.3 3 0.3 6 0.2
Females
1 0.1 2 0.2 2 0.2 5 0.1
Other malignant central nervous system
tumours
Males
2 0.2 3 0.3 7 0.6 12 0.3
Females
7 0.7 3 0.3 6 0.5 16 0.5
Other unspecified soft tissue sarcomas Males
1 0.1 5 0.4 4 0.3 10 0.3
Females
5 0.5 1 0.1 6 0.5 12 0.4
Primitive neuroectodermal tumours Males
12 1.1 10 0.9 7 0.6 29 0.9
Females
3 0.3 6 0.6 3 0.3 12 0.4
Retinoblastoma Males
7 0.6 0 0.0 0 0.0 7 0.2
Females
11 1.0 1 0.1 0 0.0 12 0.4
Rhabdomyosarcoma Males
5 0.4 4 0.4 5 0.4 14 0.4
Females
6 0.6 1 0.1 1 0.1 8 0.3
Wilms' tumour Males
16 1.4 3 0.3 0 0.0 19 0.6
Females
21 2.0 4 0.4 0 0.0 25 0.9
* Age-standardised rate, standardised to the Australian 2001 population.
CANCER INSTITUTE NSW 42
Includes people of Aboriginal and Torres Strait Islander origin.
Cancers of the colon and rectum are presented in this report both separately and together as bowel.
Melanoma refers to melanoma of the skin only.
* Age-standardised rate, standardised to the Australian 2001 population.
Data contains imputed Aboriginal statuses for missing values and is only available to 2007 due to the imputation methodology used. For further information refer to Cancer Institute
NSW publication on Cancer in NSW Aboriginal peoples: Incidence, Mortality and Survival Sydney: Cancer Institute NSW, September 2012.
CANCER IN NSW: INCIDENCE REPORT 2009
Table 36b Most common cancers, Aboriginal peoples, NSW, 19992007
Male
Rank Cancer Number ASR*
1 Prostate 239 144.5
2 Lung 206 111
3 Bowel 158 75.4
4 Head and neck 103 37.9
5 Melanoma 67 33.6
Key Facts

Prostate cancer was the most common cancer in


Aboriginal males in 19992007.

Breast cancer was the most common cancer in


Aboriginal females in 19992007.

Lung cancer incidence ranked second in both Aboriginal


males and females in 19972007.

Cervical cancer incidence ranked fourth in Aboriginal


females in 19992007.

Head and neck cancer incidence ranked fourth in


Aboriginal males in 19992007.
Table 36a New cancer cases, Aboriginal peoples, NSW, 19992007
Sex Cases ASR*
Males 1,347 660.2
Females 1,257 462.2
All People 2,604 545.2
CANCER IN ABORIGINAL PEOPLES IN NSW: INCIDENCE
Figure 31 New cancer cases, Aboriginal peoples, NSW, 1999
2007
Female
Cancer Number ASR*
Breast 346 115.7
Lung 167 68.7
Bowel 120 56
Cervical 71 19
Melanoma 62 20.2
All People
Cancer Number ASR*
Lung 373 86.5
Breast 348 63.9
Bowel 278 65.3
Prostate 239 62.5
Head and neck 142 24.4
CANCER INSTITUTE NSW 43
Includes people of Aboriginal and Torres Strait Islander origin.
Cancers of the colon and rectum are presented in this report both separately and together as bowel.
Melanoma refers to melanoma of the skin only.
Data contains imputed Aboriginal statuses for missing values and is only available to 2007 due to the imputation methodology used. For further information refer to Cancer Institute
NSW publication on Cancer in NSW Aboriginal peoples: Incidence, Mortality and Survival Sydney: Cancer Institute NSW, September 2012.
Male
Age Group
Cases
(% of Total) Cancer Number % of Total
CANCER IN NSW: INCIDENCE REPORT 2009
Table 37 Differences by age: New cases by age group, Aboriginal peoples, NSW, 19992007
Key Facts

The risk or likelihood of being diagnosed with cancer increases with age.

94 per cent of lung cancers, 73 per cent of bowel cancers, 92 per cent of prostate cancers and 48 per cent of breast cancers were
diagnosed in Aboriginal peoples aged 55 years and over.

Incidence in the Aboriginal 014 year age category has been excluded in this report, due to insufficient numbers for reporting.
CANCER IN ABORIGINAL PEOPLES IN NSW: INCIDENCE
Testicular 20 4.8%
Bowel 19 4.6%
Head and neck 18 4.4%
Melanoma 15 3.7%
Leukaemia 11 2.7%
Bowel 31 6.3%
Head and neck 31 6.2%
Lung 29 6%
Prostate 18 3.6%
NHL 16 3.2%
Prostate 83 12.2%
Lung 71 10.4%
Bowel 41 6.1%
Head and neck 30 4.4%
CUP 17 2.5%
Prostate 90 15.3%
Lung 64 10.8%
Bowel 46 7.9%
CUP 16 2.6%
Head and neck 16 2.7%
Prostate 48 12.8%
Lung 34 8.9%
Bowel 20 5.3%
Bladder 12 3.2%
Melanoma 12 3.1%
Prostate 239 9.2%
Lung 206 7.9%
Bowel 158 6.1%
Head and neck 103 3.9%
Melanoma 67 2.6%
Breast 76 18.3%
Cervical 34 8.1%
Melanoma 26 6.3%
Thyroid 16 3.8%
Bowel 15 3.5%
Breast 103 20.9%
Lung 31 6.4%
Cervical 17 3.5%
Head and neck 12 2.4%
Melanoma 11 2.3%
Breast 81 12%
Lung 55 8.2%
Bowel 30 4.5%
Uterine 18 2.6%
Ovarian 13 2%
Breast 51 8.7%
Lung 41 7%
Bowel 33 5.7%
Uterine 11 1.9%
CUP 10 1.8%
Breast 34 9%
Bowel 32 8.6%
Lung 27 7.3%
Pancreatic 9 2.4%
Uterine 9 2.5%
Breast 346 13.3%
Lung 167 6.4%
Bowel 120 4.6%
Cervical 71 2.7%
Melanoma 62 2.4%
Female
Cancer Number % of Total
1544 416 (16%)
4554 492 (18.9%)
5564 677 (26%)
6574 587 (22.5%)
75+ 378 (14.5%)
All ages 2,604 (100%)
CANCER INSTITUTE NSW 44
CANCER IN NSW: INCIDENCE REPORT 2009
Age-specific rate An age-specific rate is the rate of cancer in a specific age group, and is usually a five-year age
group and expressed per 100,00 people.
Age-standardised rate An age-standardised rate is the rate of cancer in a given population that has been standardised to
a reference population with a standard age distribution. The standardised rate is that which,
theoretically, would have been observed if the population of interest had the standard age
distribution. In this report, age-standardised rates have been given for two standard populations:
the population of Australia in 2001 and the 'World' population (SEGI).
Annual percent change (APC) The annual percent change is the average change in incidence or rates expressed as a
percentange and based on a specified period of time. It is usually derived by fitting a regression
model to the incidence or rates for a specified period.
Cancer incidence Cancer incidence refers to new cancer cases diagnosed in a given population during a specified
period.
Cases These are individual cancers. A person may have more than one cancer giving rise to multiple
cases in the same person. Second cases in one person are only counted if they are of different cell
type or originate in a different organ.
Confidence interval A range of values for a rate that has a specified probability of including the true value of the rate.
Crude rate A crude rate is the rate of cancer in a population that has not been standardised. Crude rates give
some indication of the disease burden on a population, but do not take into account the age
distribution of the population and the increase in cancer with age. Crude rates are inappropriate
for comparison between sexes, across time or between other classification groups.
Cumulative rate A weighted sum of age-specific incidence rates. The weights are the widths of the age groups. The
cumulative rate is not, in fact, a rate but a dimensionless number most conveniently expressed as
a percentage. It is a good approximation to the cumulative risk if that is less than 10 per cent.
Cumulative risk The cumulative risk is the probability that an individual will be diagnosed with cancer in the
absence of any competing causes of death during a certain age range, assuming current trends
prevail over the age range. The age range used in this report is between ages 085 years and the
cumulative risk is reported as a risk of one in.
Death certificate only (DCO) DCO cases are cases that are only identified during the processing of death certificate
information.
Morphology The type of cancer as diagnosed microscopically by a pathologist.
Rate A measure of the frequency of a phenomenon.
Topography The site or organ in the body where the cancer originates
APPENDIX 1: GLOSSARY
Definitions adapted from Last JM (ed) A Dictionary of Epidemiology 2nd edition. Oxford: Oxford University Press, 1988 and Parkin DM, Whelan SL, et al (eds).
Cancer Incidence in Five Continents Vol. VII. IARC Scientific Publications No. 143. Lyon: International Agency for Research on Cancer, 1997.
CANCER INSTITUTE NSW 45
CANCER IN NSW: INCIDENCE REPORT 2009
APPENDIX 2: CANCER REGISTRATION AND REPORTING IN NSW
The NSW Central Cancer Registry was established in 1971 as a population-based register of all cancers diagnosed in NSW residents.
Currently, notification of malignant neoplasms is a statutory requirement for public and private hospitals, departments of radiation
oncology, nursing homes, pathology laboratories, outpatient departments and day procedure centres. Data collected include demographic
information, brief medical details describing the cancer and a record of at least one episode of care from each notifier. The data are
further supplemented by pathology reports and death certificates. Insitu lesions for breast cancer and cutaneous melanoma are registered,
but not included in any reporting statistics.
Classification and coding used in this report
Primary site of cancer (topography) and cell type (morphology) are coded according to the International Classification of Diseases for
Oncology, third edition (ICD-O-3). Hospitals in NSW code disease in ICD-10 AM (Australian modification) and are required to notify the
following invasive codes: C00-C76, C80-C96. Notification of basal and squamous cell carcinoma of skin is not required (C44, M805-
M811).
For the purposes of reporting, only primary invasive cancers are counted and included in statistics. Multiple primary cancers in the same
person are counted according to the rules set out by the International Association of Cancer Registries. In this report mesothelioma,
Kaposi's sarcoma, lymphoma and other neoplasms of haematopoietic and reticuloendothelial systems are tabulated as separate entitities
and not included in the statistics for the organs in which these diseases were diagnosed.
This report is based on grouping ICD-O3 topography and morphology codes (Cancer Group Code) that are similar to ICD-10
classifications but follow earlier ICD-9 coding used in incidence and mortality reports from 1995. These reporting categories have been
used to ensure continuity of trends.
Table A2.1 Cancer groups used in this report
Cancer Group Code Tumour Groups and ICD-O-3 Codes
C00 Lip (C00)
C012 Tongue (C01,C02)
C036 Mouth (C03-C06)
C078 Salivary glands (C07,C08)
C0910 Oropharynx (C09,C10)
C11 Nasopharynx (C11)
C123 Hypopharynx (C12,C13)
C14 Other oral cavity & pharynx (C14)
C141 Head & neck (C01-C14, C30-C32)
C15 Oesophagus (C15)
C16 Stomach (C16)
C17 Small intestine (C17)
C18 Colon (C18)
C1921 Rectum, rectosigmoid, anus (C19-C21)
C219 Bowel (C18-C21)
C22 Liver (C22)
C234 Gallbladder (C23,C24)
C25 Pancreas (C25)
C301 Nose, sinuses, etc (C30,C31)
C32 Larynx (C32)
C334 Lung (C33,C34)
C378 Other thoracic organs (C37,C38)
C401 Bone (C40,C41)
C43 Melanoma of skin (C44 and M872-M879)
C44 Non-melanoma skin cancers (C44)
C45 Mesothelioma (M905)
C46 Kaposi's sarcoma (M914)
C479 Connective tissue, peripheral nerves (C47,C49)
C50 Breast (C50)
C53 Cervix (C53)
CANCER INSTITUTE NSW 46
CANCER IN NSW: INCIDENCE REPORT 2009
APPENDIX 2: CANCER REGISTRATION AND REPORTING IN NSW
Table A2.1 Cancer groups used in this report (cont.)
Cancer Group Code Tumour Groups and ICD-O-3 Codes
C545 Uterus, body & nos (C54,C55)
C567 Ovary (C56,C57.0-7)
C58 Placenta (C58)
C59 Other female genital organs (C51,C52,C57.8-9)
C598 All gynaecological (C51-C58)
C61 Prostate (C61)
C62 Testis (C62)
C6360 Other male genital organs (C60,C63)
C648 Kidney (C64-C66,C68)
C67 Bladder (C67)
C678 All urothelial (C65-C68)
C69 Eye (C69)
C71 Brain (C71)
C72 Central nervous system (C70,C72)
C73 Thyroid (C73)
C745 Other endocrine glands (C74,C75)
C81 Hodgkin's disease (M965-M966)
C82 Non-Hodgkin's lymphoma (M959,M967-M972,M976)
C821 All lymphomas (M959-M972,M976)
C8890 Multiple myeloma (M973)
C910 Acute lymphoblastic leukaemia (M9835-M9837)
C919 Other lymphoid leukaemia (M982,M983)
C920 Acute myeloid leukaemia (M9840,M9861,M9866,M9867,M9870-M9874,M9891,M9895-M9897,M991-M993)
C929 Other myeloid leukaemia (M9860,M9863,M9875,M9876,M9945,M9946,M9963)
C94 Other specified leukaemia (M9940,M9948)
C95 Unspecified leukaemia (M980)
C96 All leukaemia (M980-M994,M9963)
C98 Ill-defined & unspecified site (C26,C39,C42,C48,C76,C77,C80)
C99 All sites, excluding NMSC (C00-C80)
M95 Other lymphoid haematopoietic (C42,C77 and M974,M975, M995-M997(excluding M9963))
M96 Myelodysplasia (M998)
Clinical groupings used in this report
Clinical groupings are cancers that have been categorised using the cancer groups that are based on treatment categories. These
groupings were developed with advice from Professor Jim Bishop and endorsed by the Australasian Association of Cancer Registries
(AACR) in December 2004. Clinical groupings are derived from the defined reporting categories (Cancer Group Code).
Table A2.2 Clinical grouping categories
Clinical Group Cancer Group Code* Cancers
Skin C00, C43, C46 Lip, melanoma of skin, Kaposi's sarcoma
Head and neck
C012, C036, C078, C0910, C11, C123, C14,
C301, C32
Tongue; mouth; salivary glands; oropharynx; nasopharynx; hypopharynx;
other oral cavity & pharynx; nose, sinuses, etc; larynx
Upper Gastrointestinal C15, C16, C17, C22, C234,C25 Oesophagus, stomach, small intestine, liver, gallbladder, pancreas
Colorectal C18, C1921 Colon, rectum, rectosigmoid, anus
Respiratory C334, C378, C45 Lung, other thoracic organs, mesothelioma
Bone and other connective
tissue C401, C479 Bone, connective tissue, peripheral nerves
Breast C50 Breast
Gynaecological C53, C545, C567, C59 Cervix, uterus, body & nos, ovary, placenta, other female genital organs
Urogenital C61, C62, C6360, C648, C67 Prostate, testis, other male genital organs, kidney, bladder
Non-melanoma skin cancers are not notifiable cancers in NSW; therefore, they are not reported in any statistical or epidemiological reports at the Cancer Institute NSW.
CANCER INSTITUTE NSW 47
CANCER IN NSW: INCIDENCE REPORT 2009
APPENDIX 2: CANCER REGISTRATION AND REPORTING IN NSW
Table A2.2 Clinical grouping categories (cont.)
Clinical Group Cancer Group Code* Cancers
Eye C69 Eye
Neurological C71, C72 Brain, central nervous system
Thyroid and other endocrine C73, C745 Thyroid, other endocrine glands
Lymphohaematopoietic
C81, C82, C8890, C910, C919, C920, C929,
C94, C95
Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma,
leukaemia, myelodysplasia and other lymphoid haematopoietic
Ill-defined and unknown
primary sites C98
Other and ill-defined digestive organs, other and ill-defined respiratory
and intrathoracic organs, retroperitoneum and peritoneum, other and
ill-defined sites and unknown primary site
* Refer to table A2.1
CANCER INSTITUTE NSW 48
CANCER IN NSW: INCIDENCE REPORT 2009
APPENDIX 3: IMPACT OF MISSING DEATH CERTIFICATE DATA ON 2009
INCIDENCE
Delayed release of the Australian Bureau of Statistics (ABS) death data for 2009
The Australian Bureau of Statistics (ABS) is the national body responsible for compiling, coding and publishing mortality data (including
causes of death) from source agencies. The process of releasing potentially identifiable unit record data to users on review by the ABS,
was found to be non-compliant with the requirements of the Census and Statistics Act. Consequently, the ABS has undertaken a lengthy
series of negotiations to develop a process that will enable users to continue to receive the Cause of Death Unit Record File (CODURF)
within the confines of the Census and Statistics Act and has conducted a 'pilot' to test how the negotiated process will work. The effect
of the ABS process review and pilot has delayed the release of 2009 CODURF to the Cancer Institute NSW and has impacted the
timing and release of the cancer incidence and mortality data for 2009.
Impact on 2009 cancer incidence counts
In order to provide researchers with more relevant and updated cancer information, the 2009 cancer incidence data has been made
available for research and reporting. Mortality information has been omitted for 2009 due to the delay in receiving ABS death data. As a
result of not receiving the ABS death data, there is an expectation of underreporting of new cancer cases for 2009 of approximately 1.7
per cent for all cancers, which varies by each tumour group and age group. This proportion represents the cancer cases that are only
identified and coded as new cases on receipt and processing of the annual ABS death data and are known as 'death certificate
only' (DCO) cases. The following tables provide a breakdown of the average proportion of DCO cancer cases identifed from death data
over the five-year period from 2004 to 2008, by tumour group and age group. This information should be considered and taken into
account when performing any research or analyses using 2009 cancer incidence data.
Table A3.1 Proportion of NSW death certificate only cancer cases for 20042008 by tumour group
Cancer Group Code* Tumour Groups %DCO
C910 Acute lymphoblastic leukaemia 0.4%
C920 Acute myeloid leukaemia 1.8%
C67 Bladder 2.2%
C401 Bone 0.7%
C71 Brain 1.6%
C50 Breast 0.7%
C72 Central nervous system 1.4%
C53 Cervix 1.0%
C18 Colon 1.4%
C479 Connective tissue, peripheral nerves 0.5%
C69 Eye 0.4%
C234 Gallbladder 3.8%
C81 Hodgkin's lymphoma 0.1%
C123 Hypopharynx 0.4%
C98 Ill-defined & unspecified site 10.7%
C46 Kaposi's sarcoma 0.8%
C648 Kidney 1.7%
C32 Larynx 0.4%
C00 Lip 0.0%
C22 Liver 4.2%
C334 Lung 3.2%
C43 Melanoma of skin 0.2%
C45 Mesothelioma 2.4%
C036 Mouth 0.7%
C8890 Multiple myeloma 3.1%
C11 Nasopharynx 0.8%
C82 Non-Hodgkin's lymphoma 1.0%
C301 Nose, sinuses etc 0.4%
C15 Oesophagus 2.0%
C0910 Oropharynx 0.7%
C745 Other endocrine glands 1.6%
C59 Other female genital organs 1.3%
CANCER INSTITUTE NSW 49
CANCER IN NSW: INCIDENCE REPORT 2009
APPENDIX 3: IMPACT OF MISSING DEATH CERTIFICATE DATA ON 2009
INCIDENCE
Table A3.1 Proportion of NSW death certificate only cancer cases for 20042008 by tumour group (cont.)
Cancer Group Code* Tumour Groups %DCO
M95 Other lymphatic, haematopoietic 4.5%
C919 Other lymphoid leukaemias 4.5%
C6360 Other male genital organs 1.5%
C929 Other myeloid leukaemia 3.0%
C14 Other oral cavity & pharynx 8.1%
C94 Other specified leukaemias 2.3%
C378 Other thoracic organs 1.8%
C567 Ovary 2.6%
C25 Pancreas 5.8%
C58 Placenta 0.0%
C61 Prostate 0.9%
C1921 Rectum, rectosigmoid, anus 0.6%
C078 Salivary glands 1.1%
C17 Small intestine 0.5%
C16 Stomach 1.3%
C62 Testis 0.1%
C73 Thyroid 0.1%
C012 Tongue 1.2%
C95 Unspecified leukaemias 13.6%
C545 Uterus, body & nos 0.8%
All cancer cases 1.7%
* Refer to table A2.1
Table A3.2 Proportion of NSW death certificate only cancer cases for 20042008 by 5year age group
5Year Age Group %DCO
04 years 0.2%
1014 years 0.0%
1519 years 0.2%
2024 years 0.1%
2529 years 0.0%
3034 years 0.1%
3539 years 0.2%
4044 years 0.1%
4549 years 0.2%
5054 years 0.3%
5559 years 0.2%
59 years 0.0%
6064 years 0.3%
6569 years 0.6%
7074 years 1.0%
7579 years 1.7%
8084 years 3.5%
85+ years 10.2%
Death certificate only cancer cases as a percentage of cancer cases for each tumor group
CANCER INSTITUTE NSW 50
CANCER IN NSW: INCIDENCE REPORT 2009
APPENDIX 4: STATISTICAL CALCULATIONS USED IN THIS REPORT
The following formulae apply to calculations for either males or females or total people. The word 'cases' should be taken to mean new cancers. Age is categorised into
18 fve-year age groups from 04 years to 85 and over (85+).
Let n
j
be the number of cases in age group j for a particular cancer type; p
j
be the population at the mid-point of the year for age group j ; wj be the standard
population for age group j.
The age-specific age-specific age-specific age-specific rate rate rate rate (r
j
) per 100,000 persons for age group j for a given cancer type is found by dividing the number of cases in age group j by the corresponding
population:
The crude rate crude rate crude rate crude rate is the total number of cases for the cancer type divided by the total population:
Age-standardised Age-standardised Age-standardised Age-standardised rates rates rates rates (s) allow comparisons between different populations by using standard weights, w
j
, to calculate a summary rate from the age-specific rates.
For each cancer type, this is given by:
Cumulative Cumulative Cumulative Cumulative rate rate rate rate (CR) is a standardised rate with equal weights in each age group of interest and zero weight otherwise, and is calculated from the age-specific rates. In
this report, ages 085 years are used as an approximation to an average lifetime.
The factor of 5 appears because the age-specific rates are for five-year age groups and must be counted once for each year of life. Cumulative rates are commonly
expressed as percentages.
Cumulative Cumulative Cumulative Cumulative risk risk risk risk is a more exact measure of risk, which takes account of the sequential removal, from the population at risk, of people who are diagnosed with cancer.
It may be expressed as a percentage or, by rearranging the fraction, as a risk of 1 in n , and can be calculated from the cumulative rate:
95% confidence intervals 95% confidence intervals 95% confidence intervals 95% confidence intervals
1. Calculate the standard error:
2. Obtain upper and lower confidence intervals (UCI and LCI) for N
i
, the total number of cases for all ages for cancer type i . In this report a gamma distribution is used.
3. Calculate the required confidence intervals, LC(s) and UC(s):
Annual Percent Change Annual Percent Change Annual Percent Change Annual Percent Change
The estimated APC is calculated for each cancer type by fitting a linear regression model assuming a constant rate of change in the logarithm of the annual age-
standardised rate.
log (R
y
) = b
o
+ b
1
y
Where log (Ry) is the natural log of the rate in year Y.
The estimated slope from this model is transformed back to represent the APC increase or decrease in the age-standardised rate.
APC
i
= { (Exp (b
i
) 1) } 100
CANCER INSTITUTE NSW 51
000 , 100 =
j
j
j
p
n
r
000 , 100 rate Crude
18
1
18
1
=

=
=
j
j
j
j
p
n
s
r w
w
j j
j
j
j
=
=
=

1
1 8
1
1 8
( )
n
e
C R
=


1
1
1 0 0 /
( ) s e s
w r
r
p
w
j j
j
j j
j
j
=

=
=

2
5
1
1 8
1
1 8
1
1 0
( )
( )
( )
j
i
N LCI
N
s se
s s LC + =
( )
( )
( )
j
i
N UCI
N
s se
s s UC + =
C R r
j
j
=
=

5
1 00
10 0 000
1
1 8
,
CANCER IN NSW: INCIDENCE REPORT 2009
APPENDIX 5: NSW RESIDENTIAL POPULATION
Figure A5.1 Estimated residential population of NSW, 30 June
2009
Age
Group Male Female People
04 234,533 222,284 456,817
59 224,574 212,580 437,154
1014 229,505 217,803 447,308
1519 241,558 227,660 469,218
2024 255,068 242,667 497,735
2529 258,381 254,321 512,702
3034 241,982 244,362 486,344
3539 256,101 262,485 518,586
4044 238,633 243,770 482,403
4549 251,947 256,377 508,324
5054 230,610 235,122 465,732
5559 208,309 211,826 420,135
6064 190,973 190,927 381,900
6569 142,614 145,680 288,294
7074 110,591 119,884 230,475
7579 87,022 102,251 189,273
8084 62,767 86,450 149,217
85+ 42,677 85,413 128,090
Table A5.1 Estimated residential population of
NSW, 30 June 2009
CANCER INSTITUTE NSW 52
CANCER IN NSW: INCIDENCE REPORT 2009
APPENDIX 6: CANCER RISK TABLE
Table A6.1 Cumulative risk of incidence by cancer type, age and sex, NSW, 2009
Male Female People
Cancer
Group
Code* Cancer Type
Risk to Age 75 Risk to Age 80 Risk to Age 85 Risk to Age 75 Risk to Age 80 Risk to Age 85 Risk to Age 75 Risk to Age 80 Risk to Age 85
% 1 in n % 1 in n % 1 in n % 1 in n % 1 in n % 1 in n % 1 in n % 1 in n % 1 in n
C00 Lip 0.4 236 0.5 182 0.6 153 0.1 803 0.1 671 0.1 528 0.2 367 0.3 291 0.4 244
C012 Tongue 0.3 305 0.3 276 0.4 249 0.1 674 0.1 533 0.2 488 0.2 422 0.2 365 0.3 333
C036 Mouth 0.2 414 0.2 348 0.3 306 0.1 871 0.1 630 0.2 462 0.1 564 0.2 450 0.2 367
C078 Salivary glands 0.1 749 0.1 616 0.2 495 0 1,156 0.1 989 0.1 887 0.1 910 0.1 763 0.1 648
C0910 Oropharynx 0.2 358 0.3 302 0.3 282 0 1,784 0 1,784 0 1,784 0.1 602 0.1 527 0.2 500
C11 Nasopharynx 0 1,024 0.1 917 0.1 854 0 3,608 0 2,667 0 2,311 0 1,606 0 1,373 0 1,258
C123 Hypopharynx 0 1,036 0.1 799 0.1 553 0 5,801 0 5,801 0 5,801 0 1,775 0 1,438 0 1,075
C14 Other oral cavity and pharynx 0 2,640 0 2,292 0 1,938 0 15,577 0 15,577 0 15,577 0 4,526 0 4,043 0 3,560

C141 Head and neck 1.7 59 2.1 48 2.5 40 0.5 183 0.6 148 0.7 128 1.1 90 1.3 73 1.6 63

C15 Oesophagus 0.6 166 0.7 126 1 99 0.2 492 0.2 368 0.3 271 0.4 250 0.5 190 0.6 149
C16 Stomach 0.8 116 1.1 86 1.6 62 0.3 293 0.4 207 0.6 146 0.5 168 0.8 123 1.1 89
C17 Small intestine 0.1 591 0.2 420 0.2 371 0.1 742 0.1 592 0.1 572 0.1 659 0.2 495 0.2 457
C18 Colon 3 34 4.4 23 6.1 17 2.4 42 3.5 29 4.8 21 2.7 38 3.9 26 5.4 19
C1921 Rectal 2.2 45 3.1 32 3.8 26 1.3 75 1.7 57 2.1 46 1.7 56 2.4 42 2.9 34

C219 Bowel 5.2 20 7.5 14 10 10 3.7 27 5.2 19 7 15 4.4 23 6.3 16 8.4 12

C22 Liver 0.7 126 1.1 90 1.3 74 0.2 440 0.3 308 0.4 221 0.5 198 0.7 142 0.8 114
C234 Gallbladder 0.2 495 0.2 334 0.3 270 0.1 517 0.2 344 0.4 233 0.1 506 0.2 339 0.4 247
C25 Pancreatic 0.8 120 1.2 84 1.7 57 0.6 162 0.9 106 1.3 76 0.7 138 1 94 1.5 66

C301 Nose, sinuses, etc 0 1,255 0 1,032 0.1 828 0 2,113 0 1,752 0 1,591 0 1,578 0 1,306 0 1,111
C32 Larynx 0.4 238 0.5 169 0.7 132 0 2,264 0 1,853 0 1,526 0.2 438 0.3 320 0.3 257
C334 Lung 4 25 5.8 18 7.9 13 2.5 39 3.5 29 4.5 23 3.2 31 4.6 22 6.1 17
C378 Other thoracic organs 0 2,679 0 1,833 0 1,600 0 3,456 0 2,583 0 2,248 0 3,022 0 2,160 0 1,887

CANCER INSTITUTE NSW 53
CANCER IN NSW: INCIDENCE REPORT 2009
APPENDIX 6: CANCER RISK TABLE
Table A6.1 Cumulative risk of incidence by cancer type, age and sex, NSW, 2009 (cont.)
Male Female People
Cancer
Group
Code* Cancer Type
Risk to Age 75 Risk to Age 80 Risk to Age 85 Risk to Age 75 Risk to Age 80 Risk to Age 85 Risk to Age 75 Risk to Age 80 Risk to Age 85
% 1 in n % 1 in n % 1 in n % 1 in n % 1 in n % 1 in n % 1 in n % 1 in n % 1 in n
C401 Bone 0 1,282 0.1 991 0.1 801 0 1,576 0 1,464 0 1,167 0 1,409 0 1,188 0.1 959
C43 Melanoma 4.4 23 5.9 17 7.5 14 2.9 35 3.6 28 4.3 24 3.7 28 4.7 22 5.8 18
C45 Mesothelioma 0.3 293 0.5 181 0.8 123 0 2,026 0 1,355 0.1 672 0.1 521 0.3 331 0.4 219
C46 Kaposi's sarcoma 0 3,276 0 3,276 0 2,598 0 23,977 0 23,977 0 23,977 0 5,806 0 5,806 0 4,860
C479
Connective tissue, peripheral
nerves
0.2 448 0.2 364 0.3 289 0.1 665 0.2 490 0.2 400 0.1 537 0.2 418 0.2 338

C50 Breast 0 1,257 0.1 975 0.1 744 9.8 11 11.4 9 13 8 5 20 5.9 17 6.8 15
C53 Cervical 0 0 0 0.5 198 0.5 176 0.6 164 0.2 392 0.2 346 0.3 320
C545 Uterine 0 0 0 1.4 67 1.7 57 2 50 0.7 133 0.9 111 1 96
C567 Ovarian 0 0 0 0.7 127 0.9 102 1.1 87 0.3 251 0.5 197 0.6 167
C58 Placental 0 0 0 0 12,878 0 12,878 0 12,878 0 25,453 0 25,453 0 25,453
C59 Other female genital organs 0 0 0 0.2 395 0.3 307 0.4 233 0.1 778 0.1 595 0.2 438

C61 Prostate 17.5 6 22.7 5 27 4 0 0 0 8.6 12 11 10 12.8 8
C62 Testicular 0.4 219 0.4 216 0.4 216 0 0 0 0.2 437 0.2 432 0.2 432
C6360 Other male genital organs 0 1,964 0 1,098 0.1 720 0 0 0 0 3,987 0 2,295 0 1,571

C648 Kidney 1.3 73 1.8 55 2.2 45 0.7 133 1 99 1.2 79 1 95 1.4 71 1.7 58
C67 Bladder 0.8 113 1.4 71 2.1 47 0.2 388 0.4 242 0.6 150 0.5 177 0.8 112 1.3 74

C69 Eye 0.1 974 0.1 700 0.1 548 0.1 997 0.1 908 0.1 822 0.1 984 0.1 797 0.1 672
C71 Brain 0.6 148 0.8 125 0.9 103 0.4 234 0.5 189 0.6 166 0.5 182 0.6 151 0.7 129
C72 Central nervous system 0 2,577 0 2,245 0 1,654 0 2,141 0 1,938 0 1,743 0 2,344 0 2,086 0 1,725

C73 Thyroid 0.4 234 0.4 216 0.5 188 1.2 79 1.3 74 1.4 70 0.8 117 0.9 110 0.9 101
C745 Other endocrine glands 0 1,895 0 1,709 0 1,709 0 2,533 0 2,533 0 2,533 0 2,157 0 2,041 0 2,041

C81 Hodgkin's 0.2 474 0.2 417 0.2 368 0.1 587 0.1 555 0.1 538 0.1 523 0.2 477 0.2 442
C82 NHL 1.5 65 2 49 2.6 38 1 95 1.4 68 1.9 52 1.3 77 1.7 57 2.2 44
CANCER INSTITUTE NSW 54
CANCER IN NSW: INCIDENCE REPORT 2009
APPENDIX 6: CANCER RISK TABLE
Table A6.1 Cumulative risk of incidence by cancer type, age and sex, NSW, 2009 (cont.)
Male Female People
Cancer
Group
Code* Cancer Type
Risk to Age 75 Risk to Age 80 Risk to Age 85 Risk to Age 75 Risk to Age 80 Risk to Age 85 Risk to Age 75 Risk to Age 80 Risk to Age 85
% 1 in n % 1 in n % 1 in n % 1 in n % 1 in n % 1 in n % 1 in n % 1 in n % 1 in n
C8890 Myeloma 0.5 182 0.7 140 0.9 103 0.3 307 0.4 242 0.5 174 0.4 230 0.5 179 0.7 131

C910 Acute lymphoid leukaemia 0.1 842 0.1 803 0.1 803 0 1,225 0 1,156 0 1,084 0.1 995 0.1 945 0.1 916
C919 Other lymphoid leukaemia 0.3 266 0.5 200 0.6 150 0.1 553 0.3 330 0.3 257 0.2 361 0.4 250 0.5 192
C920 Acute myeloid leukaemia 0.3 297 0.4 201 0.6 149 0.2 437 0.2 380 0.3 268 0.2 356 0.3 268 0.5 196
C929 Other myeloid leukaemia 0.1 755 0.1 543 0.3 330 0.1 986 0.1 765 0.1 584 0.1 858 0.1 641 0.2 435
C94 Other specified leukaemia 0 1,695 0 1,544 0 1,544 0 11,325 0 11,325 0 11,325 0 2,979 0 2,761 0 2,761
C95 Unspecified leukaemia 0 3,443 0 3,443 0 2,224 0 3,484 0 2,599 0 1,998 0 3,488 0 2,945 0 2,112

C96 Leukaemia 1 96 1.4 72 1.8 54 0.6 159 0.8 121 1 93 0.8 120 1.1 91 1.4 69
C98 CUP 0.7 132 1.1 85 1.7 56 0.5 178 0.8 117 1.2 79 0.6 152 1 99 1.5 67

M95
Other lymphoid
haematopoietic
0.1 788 0.1 620 0.2 461 0.1 988 0.1 713 0.1 520 0.1 880 0.1 664 0.2 490
M96 Myelodysplasia 0.2 426 0.4 243 0.6 147 0.1 561 0.3 328 0.4 223 0.2 486 0.3 281 0.5 181

C99 All Sites, excluding NMSC 46.3 3 62.3 2 79 2 30.8 4 39 3 48 3 38.4 3 50.2 3 62.4 2
* Refer to table A2.1
CANCER INSTITUTE NSW 55
CANCER IN NSW: INCIDENCE REPORT 2009
APPENDIX 7: CANCER CASES TABLE
Table A7.1 New cases of cancers, number and percentage of all cancers by type, age and sex, NSW, 2009
Cancer
Group
Code* Cancer Type
Age Group
Sex 0-4 5-9 10-14 14-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75-79 80-84 85-89 90-94 95+ All Ages
C00 Lip M 2 7 14 14 20 16 18 23 26 18 22 13 7 200
C00 Lip F 1 1 1 3 8 5 6 7 6 8 5 7 8 5 1 72
C00 Lip P 1 3 8 17 14 28 21 24 30 32 26 27 20 15 5 1 272
C012 Tongue M 3 2 3 8 23 24 18 21 15 6 5 1 129
C012 Tongue F 3 1 3 2 3 10 6 12 6 9 8 3 3 69
C012 Tongue P 3 4 5 5 11 33 30 30 27 24 14 8 1 3 198
C036 Tongue M 1 3 7 9 14 19 14 15 8 5 5 1 101
C036 Mouth F 1 3 2 1 8 9 5 6 7 9 10 5 5 2 73
C036 Mouth P 1 1 3 5 8 17 23 24 20 22 17 15 10 6 2 174
C078 Salivary glands M 1 2 2 1 4 5 1 7 9 7 8 5 5 3 2 62
C078 Salivary glands F 1 1 2 3 3 5 2 2 3 3 7 3 2 2 1 40
C078 Salivary glands P 1 1 3 2 1 2 3 7 10 3 9 12 10 15 8 7 5 2 1 102
C0910 Oropharynx M 3 9 23 31 15 12 11 9 3 3 119
C0910 Oropharynx F 1 2 7 3 5 2 20
C0910 Oropharynx P 3 10 25 38 18 17 13 9 3 3 139
C11 Nasopharynx M 1 1 4 1 5 8 7 5 5 2 2 1 1 43
C11 Nasopharynx F 1 1 1 1 3 2 2 1 2 1 15
C11 Nasopharynx P 1 2 5 2 6 11 9 7 6 2 4 2 1 58
C123 Hypopharynx M 2 5 2 11 6 6 5 7 4 1 49
C123 Hypopharynx F 1 1 2 2 6
C123 Hypopharynx P 1 2 6 4 11 6 8 5 7 4 1 55
C14
Other oral cavity and
pharynx
M 1 1 11 1 1 1 16
C14
Other oral cavity and
pharynx
F 1 1 2
C14
Other oral cavity and
pharynx
P 1 1 1 11 2 1 1 18

C141 Head and neck M 1 2 3 2 8 8 16 41 84 113 116 102 97 69 51 26 5 744
C141 Head and neck F 1 1 1 1 4 5 12 10 12 28 32 32 30 32 26 19 8 9 4 267
C141 Head and neck P 2 1 3 4 6 13 20 26 53 112 145 148 132 129 95 70 34 14 4 1,011

C15 Oesophagus M 1 1 4 7 7 16 34 39 39 46 34 27 18 3 2 278
CANCER INSTITUTE NSW 56
CANCER IN NSW: INCIDENCE REPORT 2009
APPENDIX 7: CANCER CASES TABLE
Table A7.1 New cases of cancers, number and percentage of all cancers by type, age and sex, NSW, 2009 (cont.)
Cancer
Group
Code* Cancer Type
Age Group
Sex 0-4 5-9 10-14 14-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75-79 80-84 85-89 90-94 95+ All Ages
C15 Oesophagus F 1 1 4 4 14 13 24 14 17 25 8 1 126
C15 Oesophagus P 1 1 4 8 8 20 38 53 52 70 48 44 43 11 3 404
C16 Stomach M 1 1 3 3 3 12 19 22 30 59 62 64 53 59 28 11 430
C16 Stomach F 1 1 4 12 11 11 28 14 18 23 29 35 24 6 5 222
C16 Stomach P 1 1 1 3 4 7 24 30 33 58 73 80 87 82 94 52 17 5 652
C17 Small intestine M 3 1 2 6 10 13 13 9 12 4 3 1 77
C17 Small intestine F 3 2 5 8 2 8 9 10 7 1 7 1 63
C17 Small intestine P 6 3 7 14 12 21 22 19 19 5 10 1 1 140
C18 Colon M 2 9 7 10 22 42 76 108 170 212 267 249 219 91 33 9 1,526
C18 Colon F 1 1 2 4 3 5 7 25 43 56 86 133 183 224 226 231 141 55 17 1,443
C18 Colon P 1 1 2 6 12 12 17 47 85 132 194 303 395 491 475 450 232 88 26 2,969
C1921 Rectal M 2 2 7 15 28 44 83 117 164 153 140 158 91 51 19 1,074
C1921 Rectal F 2 5 12 25 47 67 74 84 89 79 86 72 47 12 701
C1921 Rectal P 2 4 12 27 53 91 150 191 248 242 219 244 163 98 31 1,775

C219 Bowel M 4 11 14 25 50 86 159 225 334 365 407 407 310 142 52 9 2,600
C219 Bowel F 1 1 2 4 5 10 19 50 90 123 160 217 272 303 312 303 188 67 17 2,144
C219 Bowel P 1 1 2 8 16 24 44 100 176 282 385 551 637 710 719 613 330 119 26 4,744

C22 Liver M 4 1 2 2 3 26 49 37 42 50 53 56 30 11 1 367
C22 Liver F 1 3 4 8 9 13 16 12 15 20 22 10 5 2 140
C22 Liver P 5 4 2 2 7 34 58 50 58 62 68 76 52 21 6 2 507
C234 Gallbladder M 1 1 5 12 13 11 19 17 9 11 2 1 102
C234 Gallbladder F 1 4 1 5 6 10 15 19 20 24 12 6 2 125
C234 Gallbladder P 1 1 5 1 10 18 23 26 38 37 33 23 8 3 227
C25 Pancreatic M 2 1 2 13 27 40 56 52 70 64 70 37 9 1 444
C25 Pancreatic F 1 1 4 2 8 16 19 45 41 60 68 65 35 18 5 388
C25 Pancreatic P 1 3 5 4 21 43 59 101 93 130 132 135 72 27 6 832

C301 Nose, sinuses, etc M 1 2 2 1 5 5 3 8 2 3 3 3 38
C301 Nose, sinuses, etc F 1 1 2 1 1 1 4 3 3 2 1 1 1 1 23
C301 Nose, sinuses, etc P 1 1 3 4 1 2 6 5 7 11 5 5 4 4 1 1 61
C32 Larynx M 1 2 4 9 22 25 29 37 30 21 6 1 187
C32 Larynx F 1 4 3 6 1 2 2 19
CANCER INSTITUTE NSW 57
CANCER IN NSW: INCIDENCE REPORT 2009
APPENDIX 7: CANCER CASES TABLE
Table A7.1 New cases of cancers, number and percentage of all cancers by type, age and sex, NSW, 2009 (cont.)
Cancer
Group
Code* Cancer Type
Age Group
Sex 0-4 5-9 10-14 14-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75-79 80-84 85-89 90-94 95+ All Ages
C32 Larynx P 1 2 4 10 26 28 35 38 32 23 6 1 206
C334 Lung M 1 1 3 9 17 56 100 152 250 314 334 323 260 136 32 3 1,991
C334 Lung F 1 1 1 2 9 9 43 91 116 191 208 185 201 171 89 25 5 1,348
C334 Lung P 1 1 1 2 5 18 26 99 191 268 441 522 519 524 431 225 57 8 3,339
C378 Other thoracic organs M 2 2 1 2 2 1 2 2 1 3 1 19
C378 Other thoracic organs F 1 2 1 3 1 3 1 1 2 1 16
C378 Other thoracic organs P 2 1 2 3 3 5 1 4 3 3 1 5 2 35

C401 Bone M 1 2 8 1 1 1 2 4 1 2 2 4 3 1 4 3 1 41
C401 Bone F 1 1 2 2 1 2 1 1 3 1 2 3 2 3 1 3 29
C401 Bone P 1 2 4 10 2 3 1 3 5 4 3 4 7 5 4 5 6 1 70
C43 Melanoma M 1 10 7 25 44 75 77 122 170 243 285 251 264 257 197 119 29 2 2,178
C43 Melanoma F 7 21 40 39 76 93 118 152 137 168 148 135 136 127 95 29 6 1,527
C43 Melanoma P 1 17 28 65 83 151 170 240 322 380 453 399 399 393 324 214 58 8 3,705
C45 Mesothelioma M 3 11 24 25 35 37 33 13 2 1 184
C45 Mesothelioma F 2 1 2 1 4 4 3 5 13 6 1 42
C45 Mesothelioma P 2 1 5 12 28 29 38 42 46 19 3 1 226
C46 Kaposi's sarcoma M 2 4 1 5 1 1 3 17
C46 Kaposi's sarcoma F 1 1 2
C46 Kaposi's sarcoma P 2 4 1 5 2 1 3 1 19
C479
Connective tissue,
peripheral nerves
M 2 1 1 7 1 8 2 8 3 9 6 8 8 9 12 9 9 7 1 111
C479
Connective tissue,
peripheral nerves
F 3 3 1 2 6 4 3 7 6 2 5 8 8 11 8 5 1 1 84
C479
Connective tissue,
peripheral nerves
P 5 1 1 10 2 10 8 12 6 16 12 10 13 17 20 20 17 12 2 1 195

C50 Breast M 3 3 11 8 2 4 4 4 3 42
C50 Breast F 1 4 30 49 137 293 526 553 567 672 580 370 326 272 171 42 13 4,606
C50 Breast P 1 4 30 49 137 293 526 556 570 683 588 372 330 276 175 45 13 4,648
C53 Cervical M
C53 Cervical F 5 15 24 34 32 20 25 15 23 13 13 13 7 6 4 1 250
C53 Cervical P 5 15 24 34 32 20 25 15 23 13 13 13 7 6 4 1 250
C545 Uterine M
C545 Uterine F 3 4 8 15 42 81 103 112 89 81 57 42 40 7 1 685
CANCER INSTITUTE NSW 58
CANCER IN NSW: INCIDENCE REPORT 2009
APPENDIX 7: CANCER CASES TABLE
Table A7.1 New cases of cancers, number and percentage of all cancers by type, age and sex, NSW, 2009 (cont.)
Cancer
Group
Code* Cancer Type
Age Group
Sex 0-4 5-9 10-14 14-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75-79 80-84 85-89 90-94 95+ All Ages
C545 Uterine P 3 4 8 15 42 81 103 112 89 81 57 42 40 7 1 685
C567 Ovarian M
C567 Ovarian F 1 1 5 7 8 10 16 29 40 36 52 51 37 41 28 24 8 1 395
C567 Ovarian P 1 1 5 7 8 10 16 29 40 36 52 51 37 41 28 24 8 1 395
C58 Placental M
C58 Placental F 3 1 4
C58 Placental P 3 1 4
C59
Other female genital
organs
M
C59
Other female genital
organs
F 4 5 5 7 17 8 14 18 14 15 18 6 5 136
C59
Other female genital
organs
P 4 5 5 7 17 8 14 18 14 15 18 6 5 136

C61 Prostate M 3 33 165 360 881 1,366 1,473 1,223 908 531 246 73 15 7,277
C61 Prostate F
C61 Prostate P 3 33 165 360 881 1,366 1,473 1,223 908 531 246 73 15 7,277
C62 Testicular M 10 31 40 32 45 27 25 3 6 3 3 1 1 227
C62 Testicular F
C62 Testicular P 10 31 40 32 45 27 25 3 6 3 3 1 1 227
C6360
Other male genital
organs
M 1 1 1 1 3 3 4 3 7 6 2 1 33
C6360
Other male genital
organs
F
C6360
Other male genital
organs
P 1 1 1 1 3 3 4 3 7 6 2 1 33

C648 Kidney M 2 1 3 2 6 15 23 33 52 65 92 104 73 83 51 38 5 648
C648 Kidney F 4 2 1 3 3 4 3 16 21 13 36 53 48 54 53 44 17 14 389
C648 Kidney P 6 3 1 6 5 10 18 39 54 65 101 145 152 127 136 95 55 19 1,037
C67 Bladder M 1 1 1 2 1 6 26 29 58 59 84 94 93 65 18 1 539
C67 Bladder F 2 2 2 4 12 15 18 26 32 44 31 15 5 208
C67 Bladder P 1 1 1 4 3 8 30 41 73 77 110 126 137 96 33 6 747

C69 Eye M 1 1 1 1 4 3 6 4 8 6 7 5 1 1 49
CANCER INSTITUTE NSW 59
CANCER IN NSW: INCIDENCE REPORT 2009
APPENDIX 7: CANCER CASES TABLE
Table A7.1 New cases of cancers, number and percentage of all cancers by type, age and sex, NSW, 2009 (cont.)
Cancer
Group
Code* Cancer Type
Age Group
Sex 0-4 5-9 10-14 14-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75-79 80-84 85-89 90-94 95+ All Ages
C69 Eye F 3 3 3 2 1 6 2 3 11 2 2 4 42
C69 Eye P 4 3 1 1 4 6 4 12 6 11 17 9 7 5 1 91
C71 Brain M 5 4 3 4 6 6 12 14 22 31 36 42 33 32 22 21 5 2 300
C71 Brain F 8 4 5 2 5 2 6 9 9 16 15 16 17 25 22 21 13 8 2 205
C71 Brain P 13 8 8 6 5 8 12 21 23 38 46 52 59 58 54 43 34 13 4 505
C72 Central nervous system M 1 1 2 2 2 3 3 1 2 1 18
C72 Central nervous system F 2 1 1 1 6 2 1 1 2 2 1 1 21
C72 Central nervous system P 2 1 1 1 1 1 8 4 3 4 2 5 2 3 1 39

C73 Thyroid M 1 1 5 6 12 14 23 30 21 23 22 10 11 6 9 1 195
C73 Thyroid F 1 3 2 20 36 39 62 71 49 83 53 66 31 32 15 15 4 1 583
C73 Thyroid P 2 3 3 25 42 51 76 94 79 104 76 88 41 43 21 24 5 1 778
C745 Other endocrine glands M 9 2 1 1 1 4 1 1 1 1 1 1 24
C745 Other endocrine glands F 3 2 2 3 2 3 2 17
C745 Other endocrine glands P 12 2 1 1 3 2 7 3 1 4 3 1 1 41

C81 Hodgkin's M 2 2 17 11 16 5 4 7 8 5 9 4 4 2 5 4 1 106
C81 Hodgkin's F 7 7 9 10 6 3 5 4 8 2 4 1 7 2 1 2 78
C81 Hodgkin's P 2 9 24 20 26 11 7 12 12 13 11 8 5 9 7 5 3 184
C82 NHL M 2 5 2 10 7 14 12 30 19 35 59 66 81 111 87 92 73 44 11 760
C82 NHL F 1 5 6 8 11 16 17 26 48 55 67 65 59 85 81 46 19 3 618
C82 NHL P 2 5 3 15 13 22 23 46 36 61 107 121 148 176 146 177 154 90 30 3 1,378
C8890 Myeloma M 1 4 11 20 31 36 32 43 29 33 20 4 2 266
C8890 Myeloma F 1 5 4 10 11 18 24 31 18 28 15 5 170
C8890 Myeloma P 1 1 9 15 30 42 54 56 74 47 61 35 9 2 436

C910
Acute lymphoid
leukaemia
M 18 8 7 4 2 1 1 2 1 4 2 2 1 1 1 55
C910
Acute lymphoid
leukaemia
F 15 6 1 3 1 1 3 1 1 1 2 1 1 37
C910
Acute lymphoid
leukaemia
P 33 14 8 4 5 2 1 3 4 5 3 1 2 3 2 1 1 92
C919
Other lymphoid
leukaemia
M 1 1 1 2 3 10 19 19 28 32 22 21 15 4 1 179
CANCER INSTITUTE NSW 60
CANCER IN NSW: INCIDENCE REPORT 2009
APPENDIX 7: CANCER CASES TABLE
Table A7.1 New cases of cancers, number and percentage of all cancers by type, age and sex, NSW, 2009 (cont.)
Cancer
Group
Code* Cancer Type
Age Group
Sex 0-4 5-9 10-14 14-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75-79 80-84 85-89 90-94 95+ All Ages
C919
Other lymphoid
leukaemia
F 1 1 2 6 11 10 23 25 15 12 7 113
C919
Other lymphoid
leukaemia
P 1 1 1 1 3 5 10 25 30 38 55 47 36 27 11 1 292
C920
Acute myeloid
leukaemia
M 2 1 3 7 5 4 5 4 9 4 15 12 23 22 28 22 8 9 1 184
C920
Acute myeloid
leukaemia
F 5 1 1 2 6 1 8 5 3 7 14 7 20 7 7 19 6 2 1 122
C920
Acute myeloid
leukaemia
P 7 1 4 1 9 11 5 13 9 12 11 29 19 43 29 35 41 14 11 2 306
C929
Other myeloid
leukaemia
M 1 1 1 3 2 3 7 1 7 12 4 7 9 15 6 1 80
C929
Other myeloid
leukaemia
F 1 1 3 1 3 3 2 5 1 10 5 4 6 7 8 4 64
C929
Other myeloid
leukaemia
P 1 1 2 3 2 3 5 6 9 6 8 22 9 11 15 22 14 5 144
C94
Other specified
leukaemia
M 2 1 3 4 3 2 3 3 2 1 2 26
C94
Other specified
leukaemia
F 1 2 1 4
C94
Other specified
leukaemia
P 1 2 1 3 4 3 2 3 5 2 1 3 30
C95 Unspecified leukaemia M 1 1 1 1 2 3 2 4 1 16
C95 Unspecified leukaemia F 1 2 1 2 3 1 2 2 2 16
C95 Unspecified leukaemia P 1 2 1 1 1 1 1 2 5 4 2 4 6 1 32

C96 Leukaemia M 20 10 11 6 10 8 11 9 14 24 22 46 46 62 67 61 60 36 15 2 540
C96 Leukaemia F 21 8 3 2 8 10 1 11 11 10 13 22 31 40 37 41 44 29 13 1 356
C96 Leukaemia P 41 18 14 8 18 18 12 20 25 34 35 68 77 102 104 102 104 65 28 3 896

C98 CUP M 1 1 2 5 18 24 35 50 46 61 73 77 59 16 4 472
C98 CUP F 3 1 2 2 2 2 5 14 11 21 32 41 49 60 72 72 39 8 436
C98 CUP P 4 1 3 2 2 4 10 32 35 56 82 87 110 133 149 131 55 12 908

M95
Other lymphoid
haematopoietic
M 1 1 1 3 6 7 9 6 9 6 7 7 2 65
CANCER INSTITUTE NSW 61
CANCER IN NSW: INCIDENCE REPORT 2009
APPENDIX 7: CANCER CASES TABLE
Table A7.1 New cases of cancers, number and percentage of all cancers by type, age and sex, NSW, 2009 (cont.)
Cancer
Group
Code* Cancer Type
Age Group
Sex 0-4 5-9 10-14 14-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75-79 80-84 85-89 90-94 95+ All Ages
M95
Other lymphoid
haematopoietic
F 1 2 2 2 2 4 5 2 7 6 5 8 9 5 2 62
M95
Other lymphoid
haematopoietic
P 1 3 2 3 3 7 11 9 16 12 14 14 16 12 4 127
M96 Myelodysplasia M 3 1 3 5 6 4 18 27 31 34 42 11 2 187
M96 Myelodysplasia F 1 1 1 2 2 3 7 7 8 23 26 25 19 13 138
M96 Myelodysplasia P 1 1 1 5 1 5 8 13 11 26 50 57 59 61 24 2 325

C99
All Sites, excluding
NMSC
M 48 29 23 78 91 148 174 301 383 801 1,310 2,196 3,103 3,306 3,165 2,798 2,087 1,135 310 45 21,531
C99
All Sites, excluding
NMSC
F 52 17 25 40 103 187 226 449 705 1,106 1,396 1,504 1,931 1,852 1,702 1,673 1,562 1,011 370 83 15,994
C99
All Sites, excluding
NMSC
P 100 46 48 118 194 335 400 750 1,088 1,907 2,706 3,700 5,034 5,158 4,867 4,471 3,649 2,146 680 128 37,525
* Refer to table A2.1
CANCER INSTITUTE NSW 62
CANCER IN NSW: INCIDENCE REPORT 2009
APPENDIX 8: CANCER RATE TABLE
Table A8.1 Age-specific and age-standardised incidence rates per 100,000 population by cancer type and sex, NSW, 2009
Cancer
Group
Code* Cancer Type
Age Group Standardised
Sex 0-4 5-9 10-14 14-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75-79 80-84 85+
Crude
Rate
World
Rate
Aust
Rate
C00 Lip M 0.8 2.9 5.5 5.9 7.9 6.9 8.6 12.0 18.2 16.3 25.3 20.7 16.4 5.7 3.9 5.6
C00 Lip F 0.4 0.4 0.4 1.1 3.1 2.1 2.8 3.7 4.1 6.7 4.9 8.1 16.4 2.0 1.1 1.7
C00 Lip P 0.2 0.6 1.6 3.3 2.9 5.5 4.5 5.7 7.9 11.1 11.3 14.3 13.4 16.4 3.8 2.5 3.6
C012 Tongue M 1.2 0.8 1.3 3.2 10.0 11.5 9.4 14.7 13.6 6.9 8.0 2.3 3.7 2.6 3.5
C012 Tongue F 1.2 0.4 1.1 0.8 1.2 4.3 2.8 6.3 4.1 7.5 7.8 3.5 3.5 1.9 1.3 1.8
C012 Tongue P 0.6 0.8 1.0 1.0 2.2 7.1 7.1 7.9 9.4 10.4 7.4 5.4 3.1 2.8 1.9 2.6
C036 Mouth M 0.4 1.3 2.8 3.9 6.7 9.9 9.8 13.6 9.2 8.0 14.1 2.9 1.9 2.7
C036 Mouth F 0.4 1.1 0.8 0.4 3.4 4.2 2.6 4.1 5.8 8.8 11.6 14.0 2.0 1.1 1.7
C036 Mouth P 0.2 0.2 0.6 1.0 1.6 3.7 5.5 6.3 6.9 9.5 9.0 10.1 14.1 2.5 1.5 2.2
C078 Salivary glands M 0 0.8 0.8 0.4 1.7 2.0 0.4 3.4 4.7 4.9 7.2 5.7 8.0 11.7 1.8 1.2 1.7
C078 Salivary glands F 1 0.4 0.8 1.1 1.2 2.0 0.9 0.9 1.6 2.1 5.8 2.9 2.3 3.5 1.1 0.8 1.0
C078 Salivary glands P 0 0 0.6 0.4 0.2 0.4 0.6 1.5 2.0 0.6 2.1 3.1 3.5 6.5 4.2 4.7 6.2 1.4 1.0 1.3
C0910 Oropharynx M 1.3 3.6 10.0 14.9 7.9 8.4 9.9 10.3 4.8 7.0 3.4 2.3 3.2
C0910 Oropharynx F 0.4 0.9 3.3 1.6 3.4 1.7 0.6 0.4 0.5
C0910 Oropharynx P 0.6 2.0 5.4 9.0 4.7 5.9 5.6 4.8 2.0 2.3 2.0 1.3 1.8
C11 Nasopharynx M 0.4 0.4 1.6 0.4 2.0 3.5 3.4 2.6 3.5 1.8 2.3 1.6 2.3 1.2 0.9 1.2
C11 Nasopharynx F 0.4 0.4 0.4 0.4 1.3 0.9 1.0 0.7 2.0 1.2 0.4 0.3 0.4
C11 Nasopharynx P 0.2 0.4 1.0 0.4 1.2 2.4 2.1 1.8 2.1 0.9 2.1 1.3 0.8 0.8 0.6 0.8
C123 Hypopharynx M 0.8 2.2 1.0 5.8 4.2 5.4 5.7 11.2 11.7 1.4 0.8 1.3
C123 Hypopharynx F 0.4 0.4 0.9 1.7 0.2 0.1 0.2
C123 Hypopharynx P 0.2 0.4 1.3 1.0 2.9 2.1 3.5 2.6 4.7 3.9 0.8 0.5 0.7
C14
Other oral
cavity and
pharynx
M 0.4 0.5 5.8 0.9 1.1 1.6 0.5 0.3 0.4
C14
Other oral
cavity and
pharynx
F 0 0.8 0.1 0.1 0.1
C14
Other oral
cavity and
pharynx
P 0 0.2 0.2 2.9 0.9 0.5 0.7 0.3 0.2 0.2

CANCER INSTITUTE NSW 63
CANCER IN NSW: INCIDENCE REPORT 2009
APPENDIX 8: CANCER RATE TABLE
Table A8.1 Age-specific and age-standardised incidence rates per 100,000 population by cancer type and sex, NSW, 2009 (cont.)
Cancer
Group
Code* Cancer Type
Age Group Standardised
Sex 0-4 5-9 10-14 14-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75-79 80-84 85+
Crude
Rate
World
Rate
Aust
Rate
C141 Head and neck M 0 0.8 1.2 0.8 3.3 3.1 6.7 16.3 36.4 54.2 60.7 71.5 87.7 79.3 81.3 72.6 21.2 13.9 20.1
C141 Head and neck F 0 1 0.4 0.4 1.6 2.0 4.6 4.1 4.7 11.9 15.1 16.8 20.6 26.7 25.4 22.0 24.6 7.5 4.7 6.7
C141 Head and neck P 0 0 0.6 0.8 1.2 2.7 3.9 5.4 10.4 24.0 34.5 38.8 45.8 56.0 50.2 46.9 40.6 14.3 9.2 13.1

C15 Oesophagus M 0.4 0.4 1.6 2.9 2.8 6.9 16.3 20.4 27.3 41.6 39.1 43.0 53.9 7.9 4.8 7.6
C15 Oesophagus F 0.4 0.4 1.7 1.9 7.3 8.9 20.0 13.7 19.7 39.8 3.5 1.6 2.8
C15 Oesophagus P 0.2 0.2 0.8 1.7 1.6 4.3 9.0 13.9 18.0 30.4 25.4 29.5 44.5 5.7 3.2 5.1
C16 Stomach M 0 0.4 1.2 1.2 1.2 5.0 7.5 9.5 14.4 30.9 43.5 57.9 60.9 94.0 91.4 12.3 7.3 11.8
C16 Stomach F 0.4 0.4 1.5 4.9 4.3 4.7 13.2 7.3 12.4 19.2 28.4 40.5 41.0 6.2 3.2 5.2
C16 Stomach P 0 0.2 0.2 0.6 0.8 1.3 5.0 5.9 7.1 13.8 19.1 27.7 37.7 43.3 63.0 57.8 9.2 5.2 8.3
C17 Small intestine M 1.2 0.4 0.8 2.6 4.8 6.8 9.1 8.1 13.8 6.4 9.4 2.2 1.4 2.1
C17 Small intestine F 1.1 0.8 2.0 3.4 0.9 4.2 6.2 8.3 6.8 1.2 9.4 1.8 1.1 1.6
C17 Small intestine P 1.2 0.6 1.4 3.0 2.9 5.5 7.6 8.2 10.0 3.4 9.4 2.0 1.2 1.8
C18 Colon M 0.8 3.5 2.9 3.9 9.2 16.7 33.0 51.8 89.0 148.7 241.4 286.1 348.9 311.6 43.5 25.0 42.4
C18 Colon F 0 1 0.9 1.6 1.2 2.0 2.7 10.3 16.8 23.8 40.6 69.7 125.6 186.8 221.0 267.2 249.4 40.5 20.2 33.7
C18 Colon P 0 0 0.4 1.2 2.3 2.5 3.3 9.7 16.7 28.3 46.2 79.3 137.0 213.0 251.0 301.6 270.1 42.0 22.5 37.7
C1921 Rectal M 0.8 0.8 2.9 5.9 11.7 17.5 36.0 56.2 85.9 107.3 126.6 181.6 145.0 164.0 30.6 19.0 29.4
C1921 Rectal F 0.8 2.0 4.6 10.3 18.3 28.5 34.9 44.0 61.1 65.9 84.1 83.3 69.1 19.7 11.5 17.1
C1921 Rectal P 0.4 0.8 2.5 5.2 11.0 17.9 32.2 45.5 64.9 83.9 95.0 128.9 109.2 100.7 25.1 15.1 22.8

C219 Bowel M 1.6 4.3 5.8 9.8 21.0 34.1 68.9 108.0 174.9 255.9 368.0 467.7 493.9 475.7 74.1 44.0 71.7
C219 Bowel F 0 1 0.9 1.6 2.0 4.1 7.2 20.5 35.1 52.3 75.5 113.7 186.7 252.7 305.1 350.5 318.5 60.2 31.7 50.9
C219 Bowel P 0 0 0.4 1.6 3.1 4.9 8.5 20.7 34.6 60.5 91.6 144.3 221.0 308.1 379.9 410.8 370.8 67.1 37.6 60.5

C22 Liver M 2 0.4 0.8 0.8 1.3 10.3 21.2 17.8 22.0 35.1 47.9 64.4 47.8 28.1 10.5 6.7 10.1
C22 Liver F 0 1.2 1.6 3.1 3.8 6.1 8.4 8.2 12.5 19.6 25.4 19.9 3.9 2.1 3.3
C22 Liver P 1 0.8 0.4 0.4 1.5 6.7 12.5 11.9 15.2 21.5 29.5 40.2 34.8 22.6 7.2 4.4 6.6
C234 Gallbladder M 0.4 0.4 2.2 5.8 6.8 7.7 17.2 19.5 14.3 32.8 2.9 1.7 2.8
C234 Gallbladder F 0.4 1.6 0.4 2.1 2.8 5.2 10.3 15.8 19.6 27.8 23.4 3.5 1.7 2.9
C234 Gallbladder P 0.2 0.2 1.0 0.2 2.1 4.3 6.0 9.0 16.5 19.5 22.1 26.5 3.2 1.7 2.9
CANCER INSTITUTE NSW 64
CANCER IN NSW: INCIDENCE REPORT 2009
APPENDIX 8: CANCER RATE TABLE
Table A8.1 Age-specific and age-standardised incidence rates per 100,000 population by cancer type and sex, NSW, 2009 (cont.)
Cancer
Group
Code* Cancer Type
Age Group Standardised
Sex 0-4 5-9 10-14 14-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75-79 80-84 85+
Crude
Rate
World
Rate
Aust
Rate
C25 Pancreatic M 0.8 0.4 0.8 5.2 11.7 19.2 29.3 36.5 63.3 73.5 111.5 110.1 12.7 7.2 12.3
C25 Pancreatic F 1 0.4 1.5 0.8 3.1 6.8 9.0 23.6 28.1 50.0 66.5 75.2 67.9 10.9 5.3 9.0
C25 Pancreatic P 0 0.6 1.0 0.8 4.1 9.2 14.0 26.4 32.3 56.4 69.7 90.5 82.0 11.8 6.2 10.5

C301
Nose, sinuses,
etc
M 0.4 0.8 0.8 0.4 2.2 2.4 1.6 5.6 1.8 3.4 4.8 7.0 1.1 0.7 1.0
C301
Nose, sinuses,
etc
F 0.4 0.4 0.8 0.4 0.4 0.4 2.1 2.1 2.5 2.0 1.2 3.5 0.6 0.4 0.6
C301
Nose, sinuses,
etc
P 0.2 0.2 0.6 0.8 0.2 0.4 1.3 1.2 1.8 3.8 2.2 2.6 2.7 4.7 0.9 0.6 0.8
C32 Larynx M 0.4 0.8 1.6 3.9 10.6 13.1 20.3 33.5 34.5 33.5 16.4 5.3 3.2 5.1
C32 Larynx F 0.4 1.9 1.6 4.1 0.8 2.0 2.3 0.5 0.3 0.5
C32 Larynx P 0.2 0.4 0.8 2.1 6.2 7.3 12.1 16.5 16.9 15.4 5.5 2.9 1.7 2.6
C334 Lung M 0.4 0.4 1.2 3.5 7.1 22.2 43.4 73.0 130.9 220.2 302.0 371.2 414.2 400.7 56.8 32.9 54.9
C334 Lung F 0 0.4 0.4 0.8 3.4 3.7 16.8 38.7 54.8 100.0 142.8 154.3 196.6 197.8 139.3 37.8 20.7 32.2
C334 Lung P 0 0.2 0.2 0.4 1.0 3.5 5.4 19.5 41.0 63.8 115.5 181.1 225.2 276.8 288.8 226.4 47.2 26.4 42.3
C378
Other thoracic
organs
M 0.8 0.8 0.4 0.8 0.8 0.5 1.0 1.4 0.9 3.4 1.6 0.5 0.4 0.5
C378
Other thoracic
organs
F 0.4 0.8 0.4 1.2 0.4 1.4 0.5 0.7 2.0 1.2 0.4 0.3 0.4
C378
Other thoracic
organs
P 0.4 0.2 0.4 0.6 0.6 1.0 0.2 1.0 0.8 1.0 0.4 2.6 1.3 0.5 0.4 0.5

C401 Bone M 0 1 3.3 0.4 0.4 0.4 0.8 1.7 0.4 0.9 1.0 2.1 2.1 0.9 4.6 4.8 2.3 1.2 1.0 1.2
C401 Bone F 0 1 1 0.9 0.4 0.8 0.4 0.4 1.2 0.4 0.9 1.6 1.4 2.5 1.0 3.5 0.8 0.7 0.8
C401 Bone P 0 1 1 2.1 0.4 0.6 0.2 0.6 1.0 0.8 0.6 1.0 1.8 1.7 1.7 2.6 4.0 0.8 1.0 0.9 1.0
C43 Melanoma M 0 4.1 2.7 9.7 18.2 29.3 32.3 48.4 73.7 116.7 149.2 176.0 238.7 295.3 313.9 351.5 62.1 39.8 60.1
C43 Melanoma F 3.1 8.7 15.7 16.0 29.0 38.2 46.0 64.6 64.7 88.0 101.6 112.6 133.0 146.9 152.2 42.9 27.4 38.3
C43 Melanoma P 0 3.6 5.6 12.7 17.1 29.1 35.2 47.2 69.1 90.4 118.6 138.4 173.1 207.6 217.1 218.6 52.4 33.2 48.2
C45 Mesothelioma M 1.3 5.3 12.6 17.5 31.6 42.5 52.6 37.5 5.2 2.8 5.1
C45 Mesothelioma F 0.8 0.4 0.9 0.5 2.1 2.7 2.5 4.9 15.0 8.2 1.2 0.5 0.9
C45 Mesothelioma P 0.4 0.2 1.1 2.9 7.3 10.1 16.5 22.2 30.8 18.0 3.2 1.6 2.8
CANCER INSTITUTE NSW 65
CANCER IN NSW: INCIDENCE REPORT 2009
APPENDIX 8: CANCER RATE TABLE
Table A8.1 Age-specific and age-standardised incidence rates per 100,000 population by cancer type and sex, NSW, 2009 (cont.)
Cancer
Group
Code* Cancer Type
Age Group Standardised
Sex 0-4 5-9 10-14 14-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75-79 80-84 85+
Crude
Rate
World
Rate
Aust
Rate
C46
Kaposi's
sarcoma
M 0.8 1.6 0.4 2.4 0.9 1.6 7.0 0.5 0.3 0.5
C46
Kaposi's
sarcoma
F 0.8 1.2 0.1 0.0 0.0
C46
Kaposi's
sarcoma
P 0.4 0.8 0.2 1.2 0.9 0.7 3.1 0.3 0.2 0.2
C479
Connective
tissue,
peripheral
nerves
M 1 0 0 2.9 0.4 3.1 0.8 3.1 1.3 3.6 2.6 3.8 4.2 6.3 10.9 10.3 14.3 18.7 3.2 2.4 3.1
C479
Connective
tissue,
peripheral
nerves
F 1 1.3 0.4 0.8 2.5 1.5 1.2 2.7 2.6 0.9 2.6 5.5 6.7 10.8 9.3 8.2 2.4 1.6 2.2
C479
Connective
tissue,
peripheral
nerves
P 1 0 0 2.1 0.4 2.0 1.6 2.3 1.2 3.1 2.6 2.4 3.4 5.9 8.7 10.6 11.4 11.7 2.8 2.0 2.6

C50 Breast M 1.3 1.4 5.8 5.6 1.8 4.6 6.4 16.4 1.2 0.7 1.1
C50 Breast F 0.4 1.6 11.8 20.1 52.2 120.2 205.2 235.2 267.7 352.0 398.1 308.6 318.8 314.6 264.6 129.3 85.7 116.3
C50 Breast P 0.2 0.8 5.9 10.1 26.4 60.7 103.5 119.4 135.7 178.8 204.0 161.4 174.4 185.0 181.9 65.7 44.1 60.5
C53 Cervical M
C53 Cervical F 2.1 5.9 9.8 13.0 13.1 7.8 10.6 7.1 12.0 8.9 10.8 12.7 8.1 12.9 7.0 5.3 6.8
C53 Cervical P 1.0 2.9 4.9 6.6 6.6 3.9 5.4 3.6 6.0 4.5 5.6 6.9 4.7 8.6 3.5 2.7 3.5
C545 Uterine M
C545 Uterine F 1.2 1.6 3.0 6.2 16.4 34.5 48.6 58.7 61.1 67.6 55.7 48.6 56.2 19.2 12.0 16.8
C545 Uterine P 0.6 0.8 1.5 3.1 8.3 17.4 24.5 29.3 30.9 35.1 30.1 28.1 37.5 9.7 6.2 8.8
C567 Ovarian M
C567 Ovarian F 1 0.4 2.1 2.8 3.3 3.8 6.6 11.3 17.0 17.0 27.2 35.0 30.9 40.1 32.4 38.6 11.1 7.0 9.8
C567 Ovarian P 0 0.2 1.0 1.4 1.6 1.9 3.3 5.7 8.6 8.6 13.6 17.7 16.1 21.7 18.8 25.8 5.6 3.6 5.1
C58 Placental M
C58 Placental F 1.1 0.4 0.1 0.1 0.1
C58 Placental P 0.6 0.2 0.1 0.0 0.1
CANCER INSTITUTE NSW 66
CANCER IN NSW: INCIDENCE REPORT 2009
APPENDIX 8: CANCER RATE TABLE
Table A8.1 Age-specific and age-standardised incidence rates per 100,000 population by cancer type and sex, NSW, 2009 (cont.)
Cancer
Group
Code* Cancer Type
Age Group Standardised
Sex 0-4 5-9 10-14 14-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75-79 80-84 85+
Crude
Rate
World
Rate
Aust
Rate
C59
Other female
genital organs
M
C59
Other female
genital organs
F 1.6 1.9 2.1 2.7 7.2 3.8 7.3 12.4 11.7 14.7 20.8 12.9 3.8 2.2 3.3
C59
Other female
genital organs
P 0.8 1.0 1.0 1.4 3.7 1.9 3.7 6.2 6.1 7.9 12.1 8.6 1.9 1.1 1.8

C61 Prostate M 1.2 13.8 65.5 156.1 422.9 715.3 1,032.9 1,105.9 1,043.4 846.0 782.6 207.4 129.8 194.1
C61 Prostate F
C61 Prostate P 0.6 6.8 32.5 77.3 209.7 357.7 510.9 530.6 479.7 355.9 260.8 102.9 62.8 91.9
C62 Testicular M 4.1 12.2 15.5 13.2 17.6 11.3 9.9 1.3 2.9 1.6 2.1 1.1 2.3 6.5 6.0 6.6
C62 Testicular F
C62 Testicular P 2.1 6.2 7.8 6.6 8.7 5.6 4.9 0.6 1.4 0.8 1.0 0.5 0.8 3.2 3.0 3.3
C6360
Other male
genital organs
M 0.4 0.4 0.4 0.4 1.4 1.6 2.8 2.7 8.0 9.6 7.0 0.9 0.5 0.9
C6360
Other male
genital organs
F
C6360
Other male
genital organs
P 0.2 0.2 0.2 0.2 0.7 0.8 1.4 1.3 3.7 4.0 2.3 0.5 0.3 0.4

C648 Kidney M 1 0 1.2 0.8 2.5 5.9 9.6 13.1 22.5 31.2 48.2 72.9 66.0 95.4 81.3 100.8 18.5 11.8 17.7
C648 Kidney F 2 1 0.4 1.2 1.2 1.6 1.1 6.6 8.2 5.5 17.0 27.8 32.9 45.0 51.8 50.9 36.3 10.9 6.5 9.5
C648 Kidney P 1 1 0.2 1.2 1.0 2.1 3.5 8.1 10.6 14.0 24.0 38.0 52.7 55.1 71.9 63.7 57.8 14.7 9.1 13.3
C67 Bladder M 0 0 0.4 0.8 0.4 2.4 11.3 13.9 30.4 41.4 76.0 108.0 148.2 196.8 15.4 8.2 15.2
C67 Bladder F 0.8 0.8 0.8 1.7 5.7 7.9 12.4 21.7 31.3 50.9 59.7 5.8 2.4 4.6
C67 Bladder P 0 0 0.2 0.8 0.6 1.6 6.4 9.8 19.1 26.7 47.7 66.6 91.8 105.4 10.6 5.1 9.3

C69 Eye M 0 0.4 0.4 0.4 1.6 1.3 2.9 2.1 5.6 5.4 8.0 8.0 4.7 1.4 0.9 1.3
C69 Eye F 1 1.2 1.2 0.8 0.4 2.8 1.0 2.1 9.2 2.0 2.3 4.7 1.2 0.9 1.1
C69 Eye P 1 0.6 0.2 0.2 0.8 1.2 0.9 2.9 1.6 3.8 7.4 4.8 4.7 4.7 1.3 0.9 1.2
C71 Brain M 2 2 1 1.7 2.3 2.5 4.7 5.9 8.7 13.4 17.3 22.0 23.1 28.9 25.3 33.5 16.4 8.6 6.2 8.2
C71 Brain F 4 2 2 0.9 2.1 0.8 2.5 3.4 3.7 6.2 6.4 7.6 8.9 17.2 18.4 20.5 15.0 11.7 5.8 4.3 5.3
C71 Brain P 3 2 2 1.3 1.0 1.6 2.5 4.0 4.8 7.5 9.9 12.4 15.4 20.1 23.4 22.7 22.8 13.3 7.1 5.2 6.7
CANCER INSTITUTE NSW 67
CANCER IN NSW: INCIDENCE REPORT 2009
APPENDIX 8: CANCER RATE TABLE
Table A8.1 Age-specific and age-standardised incidence rates per 100,000 population by cancer type and sex, NSW, 2009 (cont.)
Cancer
Group
Code* Cancer Type
Age Group Standardised
Sex 0-4 5-9 10-14 14-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75-79 80-84 85+
Crude
Rate
World
Rate
Aust
Rate
C72
Central
nervous system
M 0 0.4 0.8 0.9 1.0 1.6 2.7 1.1 3.2 2.3 0.5 0.4 0.5
C72
Central
nervous system
F 1 0.4 0.4 0.4 2.3 0.9 0.5 0.5 1.4 1.7 1.0 1.2 0.6 0.5 0.6
C72
Central
nervous system
P 0 0 0.2 0.2 0.2 0.2 1.6 0.9 0.7 1.0 0.7 2.2 1.1 2.0 0.8 0.6 0.4 0.5

C73 Thyroid M 0 0.4 2.0 2.3 5.0 5.5 9.6 11.9 9.1 11.0 11.5 7.0 9.9 6.9 14.3 2.3 5.6 4.3 5.4
C73 Thyroid F 1 1 0.9 8.2 14.2 16.0 23.6 29.1 19.1 35.3 25.0 34.6 21.3 26.7 14.7 17.4 5.9 16.4 12.9 15.9
C73 Thyroid P 1 1 0.6 5.0 8.2 10.5 14.7 19.5 15.5 22.3 18.1 23.0 14.2 18.7 11.1 16.1 4.7 11.0 8.6 10.7
C745
Other
endocrine
glands
M 4 1 0.4 0.4 0.4 1.6 0.4 0.5 0.5 0.7 0.9 1.1 0.7 0.8 0.7
C745
Other
endocrine
glands
F 1 0.8 0.8 1.2 0.9 1.6 1.4 0.5 0.5 0.5
C745
Other
endocrine
glands
P 3 1 0.2 0.2 0.6 0.4 1.4 0.6 0.2 1.0 1.0 0.4 0.5 0.6 0.7 0.6

C81 Hodgkin's M 1 1 7.0 4.3 6.2 2.1 1.6 2.9 3.2 2.2 4.3 2.1 2.8 1.8 5.7 6.4 2.3 3.0 2.8 3.0
C81 Hodgkin's F 3 3.1 3.7 3.9 2.5 1.1 2.1 1.6 3.4 0.9 2.1 0.7 5.8 2.0 1.2 2.3 2.2 2.1 2.2
C81 Hodgkin's P 1 2 5.1 4.0 5.1 2.3 1.3 2.5 2.4 2.8 2.6 2.1 1.7 3.9 3.7 3.4 2.3 2.6 2.4 2.6
C82 NHL M 1 2 1 4.1 2.7 5.4 5.0 11.7 8.0 13.9 25.6 31.7 42.4 77.8 78.7 105.7 116.3 128.9 21.7 14.2 21.0
C82 NHL F 1 2.2 2.5 3.1 4.5 6.1 7.0 10.1 20.4 26.0 35.1 44.6 49.2 83.1 93.7 79.6 17.4 9.8 14.9
C82 NHL P 0 1 1 3.2 2.6 4.3 4.7 8.9 7.5 12.0 23.0 28.8 38.8 61.0 63.3 93.5 103.2 96.0 19.5 11.9 17.8
C8890 Myeloma M 0.4 1.7 4.4 8.7 14.9 18.9 22.4 38.9 33.3 52.6 60.9 7.6 4.5 7.3
C8890 Myeloma F 0.4 2.1 1.6 4.3 5.2 9.4 16.5 25.9 17.6 32.4 23.4 4.8 2.5 4.0
C8890 Myeloma P 0.2 0.2 1.9 3.0 6.4 10.0 14.1 19.4 32.1 24.8 40.9 35.9 6.2 3.5 5.5

C910
Acute
lymphoid
leukaemia
M 8 4 3 1.7 0.8 0.4 0.4 0.8 0.4 1.7 1.0 1.4 0.9 1.1 2.3 1.6 2.1 1.6
CANCER INSTITUTE NSW 68
CANCER IN NSW: INCIDENCE REPORT 2009
APPENDIX 8: CANCER RATE TABLE
Table A8.1 Age-specific and age-standardised incidence rates per 100,000 population by cancer type and sex, NSW, 2009 (cont.)
Cancer
Group
Code* Cancer Type
Age Group Standardised
Sex 0-4 5-9 10-14 14-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75-79 80-84 85+
Crude
Rate
World
Rate
Aust
Rate
C910
Acute
lymphoid
leukaemia
F 7 3 1 1.2 0.4 0.4 1.2 0.4 0.5 0.5 1.7 1.0 1.2 1.0 1.5 1.1
C910
Acute
lymphoid
leukaemia
P 7 3 2 0.9 1.0 0.4 0.2 0.6 0.8 1.1 0.7 0.3 0.7 1.3 1.1 0.7 0.8 1.3 1.8 1.3
C919
Other
lymphoid
leukaemia
M 0.4 0.4 0.4 0.8 1.2 4.3 9.1 9.9 19.6 28.9 25.3 33.5 46.9 5.1 3.0 5.0
C919
Other
lymphoid
leukaemia
F 0.4 0.4 0.8 2.8 5.8 6.9 19.2 24.4 17.4 22.2 3.2 1.5 2.6
C919
Other
lymphoid
leukaemia
P 0.2 0.2 0.2 0.2 0.6 1.0 2.1 6.0 7.9 13.2 23.9 24.8 24.1 30.4 4.1 2.2 3.7
C920
Acute myeloid
leukaemia
M 1 0 1 2.7 1.9 1.7 2.0 1.7 3.6 1.7 7.2 6.3 16.1 19.9 32.2 35.1 42.2 5.2 3.4 5.2
C920
Acute myeloid
leukaemia
F 2 1 0.4 0.8 2.4 0.4 3.0 2.1 1.2 3.0 6.6 3.7 13.7 5.8 6.8 22.0 10.5 3.4 2.3 3.0
C920
Acute myeloid
leukaemia
P 2 0 1 0.2 1.8 2.1 1.0 2.5 1.9 2.4 2.4 6.9 5.0 14.9 12.6 18.5 27.5 21.1 4.3 2.8 4.0
C929
Other myeloid
leukaemia
M 0 0.4 0.4 1.2 0.8 1.3 2.8 0.4 3.4 6.3 2.8 6.3 10.3 23.9 16.4 2.3 1.4 2.2
C929
Other myeloid
leukaemia
F 1 0.4 1.2 0.4 1.1 1.2 0.8 2.1 0.5 5.2 3.4 3.3 5.9 8.1 14.0 1.8 1.1 1.5
C929
Other myeloid
leukaemia
P 0 0 0.4 0.6 0.4 0.6 1.0 1.2 1.8 1.3 1.9 5.8 3.1 4.8 7.9 14.7 14.8 2.0 1.2 1.8
C94
Other specified
leukaemia
M 0.8 0.4 1.3 1.6 1.3 1.0 1.6 2.1 1.8 1.1 4.7 0.7 0.5 0.7
C94
Other specified
leukaemia
F 0.4 1.4 1.2 0.1 0.1 0.1
C94
Other specified
leukaemia
P 0.2 0.4 0.2 0.6 0.8 0.6 0.5 0.8 1.7 0.9 0.5 2.3 0.4 0.3 0.4
C95
Unspecified
leukaemia
M 0 0.4 0.4 0.5 1.4 2.7 3.2 11.7 0.5 0.3 0.5
C95
Unspecified
leukaemia
F 0 1 0.4 1.0 2.1 0.8 2.0 2.3 2.3 0.4 0.3 0.4
C95
Unspecified
leukaemia
P 0 1 0 0.2 0.2 0.2 0.2 0.5 1.7 1.7 1.1 2.7 5.5 0.5 0.3 0.4
CANCER INSTITUTE NSW 69
CANCER IN NSW: INCIDENCE REPORT 2009
APPENDIX 8: CANCER RATE TABLE
Table A8.1 Age-specific and age-standardised incidence rates per 100,000 population by cancer type and sex, NSW, 2009 (cont.)
Cancer
Group
Code* Cancer Type
Age Group Standardised
Sex 0-4 5-9 10-14 14-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70-74 75-79 80-84 85+
Crude
Rate
World
Rate
Aust
Rate

C96 Leukaemia M 9 5 5 2.5 3.9 3.1 4.5 3.5 5.9 9.5 9.5 22.1 24.1 43.5 60.6 70.1 95.6 124.2 15.4 10.7 15.1
C96 Leukaemia F 9 4 1 0.9 3.3 3.9 0.4 4.2 4.5 3.9 5.5 10.4 16.2 27.5 30.9 40.1 50.9 50.3 10.0 6.8 8.7
C96 Leukaemia P 9 4 3 1.7 3.6 3.5 2.5 3.9 5.2 6.7 7.5 16.2 20.2 35.4 45.1 53.9 69.7 74.9 12.7 8.6 11.6

C98 CUP M 0 0.4 0.8 2.1 7.1 10.4 16.8 26.2 32.3 55.2 83.9 122.7 185.1 13.5 7.4 13.3
C98 CUP F 1 1 0.8 0.8 0.8 0.8 2.1 5.5 4.7 9.9 16.8 28.1 40.9 58.7 83.3 139.3 12.2 5.5 9.7
C98 CUP P 1 0 0.6 0.4 0.4 0.8 2.1 6.3 7.5 13.3 21.5 30.2 47.7 70.3 99.9 154.6 12.8 6.4 11.3

M95
Other
lymphoid
haematopoietic
M 0.4 0.4 0.4 1.2 2.6 3.4 4.7 4.2 8.1 6.9 11.2 21.1 1.9 1.1 1.8
M95
Other
lymphoid
haematopoietic
F 0.4 0.8 0.8 0.8 0.8 1.6 2.1 0.9 3.7 4.1 4.2 7.8 10.4 8.2 1.7 1.0 1.5
M95
Other
lymphoid
haematopoietic
P 0.2 0.6 0.4 0.6 0.6 1.4 2.4 2.1 4.2 4.2 6.1 7.4 10.7 12.5 1.8 1.1 1.6
M96 Myelodysplasia M 1.2 0.4 1.2 2.2 2.9 2.1 12.6 24.4 35.6 54.2 128.9 5.3 2.6 5.5
M96 Myelodysplasia F 0.4 0.4 0.4 0.8 0.8 1.3 3.3 3.7 5.5 19.2 25.4 28.9 37.5 3.9 1.7 3.1
M96 Myelodysplasia P 0.2 0.2 0.2 1.0 0.2 1.0 1.7 3.1 2.9 9.0 21.7 30.1 39.5 67.9 4.6 2.0 4.0

C99
All Sites,
excluding
NMSC
M 21 13 10 32.3 35.7 57.3 71.9 117.5 160.5 317.9 568.1 1,054.2 1,624.8 2,318.1 2,861.9 3,215.3 3,325.0 3,491.3 613.8 383.6 588.2
C99
All Sites,
excluding
NMSC
F 23 8 12 17.6 42.4 73.5 92.5 171.1 289.2 431.4 593.7 710.0 1,011.4 1,271.3 1,419.7 1,636.2 1,806.8 1,714.0 449.0 273.6 393.5
C99
All Sites,
excluding
NMSC
P 22 11 11 25.1 39.0 65.3 82.2 144.6 225.5 375.2 581.0 880.7 1,318.1 1,789.1 2,111.7 2,362.2 2,445.4 2,306.2 530.8 325.2 481.9
* Refer to table A2.1
CANCER INSTITUTE NSW 70
CANCER IN NSW: INCIDENCE REPORT 2009
APPENDIX 9: CANCER SUMMARY TABLE
Table A9.1 Summary of age-standardised cancer incidence, crude and cumulative incidence rates, NSW, 2009
MALE FEMALE PEOPLE
Cancer
Group
Code* Cancer Type
Standardised Rate Standardised Rate
No. % Crude World Aust2001 No. % Crude World Aust2001 No. %
C00 Lip 200 0.9 5.7 5.6 (4.8 - 6.4) 5.6 (4.8 - 6.4) 72 0.5 2 1.7 (1.3 - 2.1) 1.7 (1.3 - 2.1) 272 0.7
C012 Tongue 129 0.6 3.7 3.5 (2.9 - 4.1) 3.5 (2.9 - 4.1) 69 0.4 1.9 1.8 (1.4 - 2.2) 1.8 (1.4 - 2.2) 198 0.5
C036 Mouth 101 0.5 2.9 2.7 (2.2 - 3.3) 2.7 (2.2 - 3.3) 73 0.5 2 1.7 (1.3 - 2.2) 1.7 (1.3 - 2.2) 174 0.5
C078 Salivary glands 62 0.3 1.8 1.7 (1.3 - 2.2) 1.7 (1.3 - 2.2) 40 0.3 1.1 1.0 (0.7 - 1.4) 1.0 (0.7 - 1.4) 102 0.3
C0910 Oropharynx 119 0.6 3.4 3.2 (2.6 - 3.8) 3.2 (2.6 - 3.8) 20 0.1 0.6 0.5 (0.3 - 0.8) 0.5 (0.3 - 0.8) 139 0.4
C11 Nasopharynx 43 0.2 1.2 1.2 (0.8 - 1.6) 1.2 (0.8 - 1.6) 15 0.1 0.4 0.4 (0.2 - 0.7) 0.4 (0.2 - 0.7) 58 0.2
C123 Hypopharynx 49 0.2 1.4 1.3 (1.0 - 1.8) 1.3 (1.0 - 1.8) 6 0 0.2 0.2 (0.1 - 0.4) 0.2 (0.1 - 0.4) 55 0.1
C14
Other oral cavity
and pharynx
16 0.1 0.5 0.4 (0.2 - 0.6) 0.4 (0.2 - 0.6) 2 0 0.1 0.1 (0.0 - 0.2) 0.1 (0.0 - 0.2) 18 0

C141 Head and neck 744 3.5 21.2 20.1 (18.7 - 21.6) 20.1 (18.7 - 21.6) 267 1.7 7.5 6.7 (5.9 - 7.5) 6.7 (5.9 - 7.5) 1,011 2.7

C15 Oesophagus 278 1.3 7.9 7.6 (6.7 - 8.6) 7.6 (6.7 - 8.6) 126 0.8 3.5 2.8 (2.3 - 3.3) 2.8 (2.3 - 3.3) 404 1.1
C16 Stomach 430 2 12.3 11.8 (10.7 - 13.0) 11.8 (10.7 - 13.0) 222 1.4 6.2 5.2 (4.6 - 6.0) 5.2 (4.6 - 6.0) 652 1.7
C17 Small intestine 77 0.4 2.2 2.1 (1.6 - 2.6) 2.1 (1.6 - 2.6) 63 0.4 1.8 1.6 (1.2 - 2.0) 1.6 (1.2 - 2.0) 140 0.4
C18 Colon 1,526 7.1 43.5 42.4 (40.3 - 44.6) 42.4 (40.3 - 44.6) 1,443 9 40.5 33.7 (32.0 - 35.5) 33.7 (32.0 - 35.5) 2,969 7.9
C1921 Rectal 1,074 5 30.6 29.4 (27.6 - 31.2) 29.4 (27.6 - 31.2) 701 4.4 19.7 17.1 (15.9 - 18.5) 17.1 (15.9 - 18.5) 1,775 4.7

C219 Bowel 2,600 12.1 74.1 71.7 (69.0 - 74.6) 71.7 (69.0 - 74.6) 2,144 13.4 60.2 50.9 (48.7 - 53.1) 50.9 (48.7 - 53.1) 4,744 12.6

C22 Liver 367 1.7 10.5 10.1 (9.1 - 11.2) 10.1 (9.1 - 11.2) 140 0.9 3.9 3.3 (2.8 - 3.9) 3.3 (2.8 - 3.9) 507 1.4
C234 Gallbladder 102 0.5 2.9 2.8 (2.3 - 3.5) 2.8 (2.3 - 3.5) 125 0.8 3.5 2.9 (2.4 - 3.5) 2.9 (2.4 - 3.5) 227 0.6
C25 Pancreatic 444 2.1 12.7 12.3 (11.2 - 13.5) 12.3 (11.2 - 13.5) 388 2.4 10.9 9.0 (8.1 - 10.0) 9.0 (8.1 - 10.0) 832 2.2

C301 Nose, sinuses, etc 38 0.2 1.1 1.0 (0.7 - 1.4) 1.0 (0.7 - 1.4) 23 0.1 0.6 0.6 (0.4 - 0.9) 0.6 (0.4 - 0.9) 61 0.2
C32 Larynx 187 0.9 5.3 5.1 (4.4 - 5.9) 5.1 (4.4 - 5.9) 19 0.1 0.5 0.5 (0.3 - 0.7) 0.5 (0.3 - 0.7) 206 0.5
C334 Lung 1,991 9.2 56.8 54.9 (52.5 - 57.4) 54.9 (52.5 - 57.4) 1,348 8.4 37.8 32.2 (30.4 - 33.9) 32.2 (30.4 - 33.9) 3,339 8.9
C378
Other thoracic
organs
19 0.1 0.5 0.5 (0.3 - 0.8) 0.5 (0.3 - 0.8) 16 0.1 0.4 0.4 (0.2 - 0.7) 0.4 (0.2 - 0.7) 35 0.1

C401 Bone 41 0.2 1.2 1.2 (0.8 - 1.6) 1.2 (0.8 - 1.6) 29 0.2 0.8 0.8 (0.5 - 1.1) 0.8 (0.5 - 1.1) 70 0.2
CANCER INSTITUTE NSW 71
CANCER IN NSW: INCIDENCE REPORT 2009
APPENDIX 9: CANCER SUMMARY TABLE
Table A9.1 Summary of age-standardised cancer incidence, crude and cumulative incidence rates, NSW, 2009 (cont.)
MALE FEMALE PEOPLE
Cancer
Group
Code* Cancer Type
Standardised Rate Standardised Rate
No. % Crude World Aust2001 No. % Crude World Aust2001 No. %
C43 Melanoma 2,178 10.1 62.1 60.1 (57.6 - 62.7) 60.1 (57.6 - 62.7) 1,527 9.5 42.9 38.3 (36.4 - 40.3) 38.3 (36.4 - 40.3) 3,705 9.9
C45 Mesothelioma 184 0.9 5.2 5.1 (4.4 - 5.9) 5.1 (4.4 - 5.9) 42 0.3 1.2 0.9 (0.7 - 1.3) 0.9 (0.7 - 1.3) 226 0.6
C46 Kaposi's sarcoma 17 0.1 0.5 0.5 (0.3 - 0.8) 0.5 (0.3 - 0.8) 2 0 0.1 0.0 (0.0 - 0.2) 0.0 (0.0 - 0.2) 19 0.1
C479
Connective tissue,
peripheral nerves
111 0.5 3.2 3.1 (2.6 - 3.8) 3.1 (2.6 - 3.8) 84 0.5 2.4 2.2 (1.7 - 2.7) 2.2 (1.7 - 2.7) 195 0.5

C50 Breast 42 0.2 1.2 1.1 (0.8 - 1.5) 1.1 (0.8 - 1.5) 4,606 28.8 129.3 116.3 (112.9 - 119.7) 116.3 (112.9 - 119.7) 4,648 12.4
C53 Cervical 0 0 250 1.6 7 6.8 (5.9 - 7.7) 6.8 (5.9 - 7.7) 250 0.7
C545 Uterine 0 0 685 4.3 19.2 16.8 (15.6 - 18.2) 16.8 (15.6 - 18.2) 685 1.8
C567 Ovarian 0 0 395 2.5 11.1 9.8 (8.9 - 10.8) 9.8 (8.9 - 10.8) 395 1.1
C58 Placental 0 0 4 0 0.1 0.1 (0.0 - 0.3) 0.1 (0.0 - 0.3) 4 0
C59
Other female
genital organs
0 0 136 0.9 3.8 3.3 (2.8 - 4.0) 3.3 (2.8 - 4.0) 136 0.4

C61 Prostate 7,277 33.8 207.4 194.1 (189.7 - 198.7) 194.1 (189.7 - 198.7) 0 0 7,277 19.4
C62 Testicular 227 1.1 6.5 6.6 (5.7 - 7.5) 6.6 (5.7 - 7.5) 0 0 227 0.6
C6360
Other male genital
organs
33 0.2 0.9 0.9 (0.6 - 1.3) 0.9 (0.6 - 1.3) 0 0 33 0.1

C648 Kidney 648 3 18.5 17.7 (16.4 - 19.2) 17.7 (16.4 - 19.2) 389 2.4 10.9 9.5 (8.6 - 10.5) 9.5 (8.6 - 10.5) 1,037 2.8
C67 Bladder 539 2.5 15.4 15.2 (13.9 - 16.5) 15.2 (13.9 - 16.5) 208 1.3 5.8 4.6 (4.0 - 5.3) 4.6 (4.0 - 5.3) 747 2

C69 Eye 49 0.2 1.4 1.3 (1.0 - 1.8) 1.3 (1.0 - 1.8) 42 0.3 1.2 1.1 (0.8 - 1.5) 1.1 (0.8 - 1.5) 91 0.2
C71 Brain 300 1.4 8.6 8.2 (7.3 - 9.2) 8.2 (7.3 - 9.2) 205 1.3 5.8 5.3 (4.6 - 6.1) 5.3 (4.6 - 6.1) 505 1.3
C72
Central nervous
system
18 0.1 0.5 0.5 (0.3 - 0.8) 0.5 (0.3 - 0.8) 21 0.1 0.6 0.6 (0.3 - 0.9) 0.6 (0.3 - 0.9) 39 0.1

C73 Thyroid 195 0.9 5.6 5.4 (4.7 - 6.3) 5.4 (4.7 - 6.3) 583 3.6 16.4 15.9 (14.6 - 17.2) 15.9 (14.6 - 17.2) 778 2.1
C745
Other endocrine
glands
24 0.1 0.7 0.7 (0.4 - 1.0) 0.7 (0.4 - 1.0) 17 0.1 0.5 0.5 (0.3 - 0.7) 0.5 (0.3 - 0.7) 41 0.1

C81 Hodgkin's 106 0.5 3 3.0 (2.4 - 3.6) 3.0 (2.4 - 3.6) 78 0.5 2.2 2.2 (1.7 - 2.7) 2.2 (1.7 - 2.7) 184 0.5
C82 NHL 760 3.5 21.7 21.0 (19.6 - 22.6) 21.0 (19.6 - 22.6) 618 3.9 17.4 14.9 (13.8 - 16.2) 14.9 (13.8 - 16.2) 1,378 3.7
CANCER INSTITUTE NSW 72
CANCER IN NSW: INCIDENCE REPORT 2009
APPENDIX 9: CANCER SUMMARY TABLE
Table A9.1 Summary of age-standardised cancer incidence, crude and cumulative incidence rates, NSW, 2009 (cont.)
MALE FEMALE PEOPLE
Cancer
Group
Code* Cancer Type
Standardised Rate Standardised Rate
No. % Crude World Aust2001 No. % Crude World Aust2001 No. %
C8890 Myeloma 266 1.2 7.6 7.3 (6.4 - 8.2) 7.3 (6.4 - 8.2) 170 1.1 4.8 4.0 (3.4 - 4.7) 4.0 (3.4 - 4.7) 436 1.2

C910
Acute lymphoid
leukaemia
55 0.3 1.6 1.6 (1.2 - 2.1) 1.6 (1.2 - 2.1) 37 0.2 1 1.1 (0.8 - 1.5) 1.1 (0.8 - 1.5) 92 0.2
C919
Other lymphoid
leukaemia
179 0.8 5.1 5.0 (4.2 - 5.7) 5.0 (4.2 - 5.7) 113 0.7 3.2 2.6 (2.2 - 3.2) 2.6 (2.2 - 3.2) 292 0.8
C920
Acute myeloid
leukaemia
184 0.9 5.2 5.2 (4.4 - 6.0) 5.2 (4.4 - 6.0) 122 0.8 3.4 3.0 (2.5 - 3.6) 3.0 (2.5 - 3.6) 306 0.8
C929
Other myeloid
leukaemia
80 0.4 2.3 2.2 (1.8 - 2.8) 2.2 (1.8 - 2.8) 64 0.4 1.8 1.5 (1.2 - 1.9) 1.5 (1.2 - 1.9) 144 0.4
C94
Other specified
leukaemia
26 0.1 0.7 0.7 (0.5 - 1.1) 0.7 (0.5 - 1.1) 4 0 0.1 0.1 (0.0 - 0.2) 0.1 (0.0 - 0.2) 30 0.1
C95
Unspecified
leukaemia
16 0.1 0.5 0.5 (0.3 - 0.8) 0.5 (0.3 - 0.8) 16 0.1 0.4 0.4 (0.2 - 0.6) 0.4 (0.2 - 0.6) 32 0.1

C96 Leukaemia 540 2.5 15.4 15.1 (13.9 - 16.5) 15.1 (13.9 - 16.5) 356 2.2 10 8.7 (7.8 - 9.7) 8.7 (7.8 - 9.7) 896 2.4

C98 CUP 472 2.2 13.5 13.3 (12.1 - 14.5) 13.3 (12.1 - 14.5) 436 2.7 12.2 9.7 (8.7 - 10.6) 9.7 (8.7 - 10.6) 908 2.4

M95
Other lymphoid
haematopoietic
65 0.3 1.9 1.8 (1.4 - 2.3) 1.8 (1.4 - 2.3) 62 0.4 1.7 1.5 (1.1 - 1.9) 1.5 (1.1 - 1.9) 127 0.3
M96 Myelodysplasia 187 0.9 5.3 5.5 (4.7 - 6.3) 5.5 (4.7 - 6.3) 138 0.9 3.9 3.1 (2.6 - 3.7) 3.1 (2.6 - 3.7) 325 0.9

C99
All Sites, excluding
NMSC
21,531 100 613.8 588.2 (580.3 - 596.2) 588.2 (580.3 - 596.2) 15,994 100 449 393.5 (387.3 - 399.7) 393.5 (387.3 - 399.7) 37,525 100
* Refer to table A2.1
CANCER INSTITUTE NSW 73
Australian Technology Park
Level 9, 8 Central Avenue,
Eveleigh NSW 2015
PO Box 41
Alexandria NSW 1435
Tel: +61 2 8374 5600
Fax: +61 2 8374 3600
Email: information@cancerinstitute.org.au
www.cancerinstitute.org.au

S-ar putea să vă placă și